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ABSTRACT
The objective of this work is to functionalize an existing polymer such that it better
mimics natural tissue for tissue growth and regeneration. Numerous other processes have
tried and accomplished this by non-specific protein adsorption, covalent attachment,
biomolecule entanglement, and synthesis of new polymers with the desired functionality.
The focus of this work is to modify the polymer's binding capability to cells while not
altering the bulk properties. Through the use of both phage display of peptide libraries
and yeast surface display of scFv libraries the surface of chlorine-doped polypyrrole
(PPyCl) has been modified to facilitate binding of neuronal phenotype cells. The
selection of peptides using phage display found a surface specific recognition peptide
(T59) that was made bivalent by altering the C-terminus with an integrin binding epitope.
The bivalency of the modified T59 peptide was exploited to tether phenochromocytoma
(PC12) cells to the surface of PPyCl. Furthermore the tethering of the cells to PPyCl
through the peptide does not decrease the cells neuronal function and maintains the bulk
conductive polymers characteristics. Using the peptide as a bivalent linker, the addition
of other types of cells, drugs, growth factors, and enzymes could be incorporated for
various biomedical applications. An antibody (Y2) specific to PPyC1 was found using
yeast surface display. This antibody was utilized to mediate cellular binding to PPyCl by
expression of the antibody on the surface of PC12 cells. Complimenting the peptide
studies of having an exterior bivalent linker the antibody recognition provides the means
for any cell type to adhere to PPyCl, through expression of the antibody on the surface of
the cell. This type of system could be used for various types of tissue growth supports.
Thesis Supervisor: Angela Belcher
Title: Professor of Biological Engineering
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CHAPTER 1: Introduction
1.1 Objectives of this Study
The objective of this project is to functionalize an existing polymer such that it
better mimics natural tissue for tissue growth and regeneration. By using a random
bacteriophage library that displays a peptide insert on the gPIII of a bacteriophage protein
capsid, x 109 random peptide inserts were rapidly screened against a polymer of interest.
As an alternative to the peptide selection, a yeast surface display library was used to
screen human derived single chain fragment antibodies (scFv) against the surface of the
polymer to reverse engineer cell-binding to the polymer surface. Specifically, peptides
were selected using bacteriophage display and scFv using yeast surface display that bind
directly to the polymer, oxidized polypyrrole doped with chlorine (PPyCl).
By selecting and identifying individual peptides that bind specifically to
polymers, one can quickly and easily synthesize the peptides with the polymer binding
domain on one terminus, and a domain that binds to cells, drugs, or growth factors on the
other. These selected peptides could be used as bi-functional linkers to attach a wide
variety of biologically active molecules to a biomaterial surface. Since this approach can
be used for existing materials, no changes to the biomaterial's physical properties or re-
characterization of the biomaterial would be necessary. The versatility of this technique is
demonstrated by the ability to modify many different types of existing biomaterials. This
represents a clear advantage over present approaches to modify synthetic polymers,
which include non-specific protein adsorption, covalent attachment methods, and the
synthesis of entirely new polymers with desired functionality.
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Using yeast surface display to screen scFv against the PPyCl surface as an
alternative to bacteriophage display presents two major advantages. First, the
bacteriophage length scale is extremely small (6 nm X 880 nm) and there is difficulty in
visualizing an individual bacteriophage particle. Although the scFv is on the same order
of magnitude as the phage, the use of the yeast cellular surface to display the scFv
provides a much larger particle to image with a yeast cell being 3-5 jtm. Second, knowing
the scFv sequence one can manufacture a biological label for PPyCl, as can the peptide
from the bacteriophage. But the major advantage of knowing the scFv sequence is that it
provides a large enough surface area on a foreign cell for that cell to bind to PPyCl,
through the scFv linkage.
As described above, the goal of this work is to understand the binding of the
selected peptides while creating a novel bi-functional linker between a polymeric surface
and cells or biomolecules. Additionally, a secondary aim for this work is to evaluate the
ability to screen scFv against polymers and then incorporate them into different species to
evaluate relative binding affinity. Figures 1.1 and 1.2 illustrate the microscopic type of
interactions that will be created between biomolecules, the polymer, and cells.
10
* Binding motif (Arg-Gly-Asp) Peptide/scFv
Figure 1.1: Microscopic illustration of bi-functional linker.
Once determined, the peptide sequence that binds to the surface of the biomaterial
will be used incorporated with binding motifs for nerve-like cells, such as arginine-
glycine-aspartic acid (RGD), thus creating a bi-functional linker between materials and
cells. A brief diagram of the cellular attachment through motif modification and nerve
regeneration capabilities is shown in Figure 1.2.
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Nerve Cell
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Figure 1.2: Microscopic illustration of the bi-functional system used inside a host.
By using these types of connections between materials and cells the effectiveness
of a nerve guidance channel created from these pieces will increase compared to that of
the nerve autograft. The nerve autograft has the largest average recovery of function rate
for nerve damage (-50%), but it requires multiple surgeries which incorporate increased
possibility of infection [1]. By providing a surface modified biomaterial and a
concentration gradient of cells and biomolecules the limitations of the nerve autograft
hope to be surpassed, thus far these ideas can not be accomplished with the current use of
autografts.
1.2 Previous Techniques Used for Biomaterial Surface Modification
This research centers on new ways to generate hybrid-biomaterials that better
resemble natural tissue. These materials will be useful for a wide range of tissue
engineering applications in which materials and cells are combined to reconstruct living
tissue, or in which materials on their own are used to stimulate the regeneration of
damaged tissue directly in the body. Applications may include therapies for nerve
12
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regeneration [2-5], bioreactors [6], biosensors [7], and organ-specific tissue regeneration
[8-12].
There are various approaches that researchers have taken to make non-biological
materials resemble natural biological tissue. Through protein adsorption [ 13], synthesis of
graft-copolymers [14], non-covalent surface modification [15], and entanglement [16-18]
attempts have been made to create a biomaterial that is flexible to changes in molecular
design, is easy to synthesize, and is adaptable for a broad range of applications.
Researchers have investigated methods for the microfabrication of biological
surfaces by attaching proteins and other biomolecules for specific molecular recognition
and cell attachment [13]. For example, microcontact printing using a PDMS stamp has
often been used to create micropatterns, followed by the adsorption of proteins and cells
to the solid surface. Since protein adsorption is largely dependent upon non-specific
interactions between the protein and the surface, the stamping method using proteins does
not consistently orient the adsorbed proteins to expose the desired functionalities [ 13].
Other investigators have engineered polymer surfaces to create materials that
control cellular adhesion and maintain differentiated phenotypic expression [14].
Because of the absence of suitable functional groups on the surface of many polymers to
covalently attach peptides, many groups have investigated methods for modifying the
chemistry of these polymer surfaces. Common approaches involve introducing reactive
groups, such as poly(L-lysine), at existing polymer surfaces by incorporating monomer
units with appropriate functionality into the polymer backbone to create new polymer
materials [19]. However, such approaches often require complicated synthetic pathways,
and lack consistent surface coverage of the grafted biomolecules [ 14].
13
An alternative method to functionalize materials uses a silanization technique to
immobilize peptides. This method was demonstrated by utilizing silane films deposited
on titanium oxide surfaces with terminal functional groups that can be further modified
with different bi-functional linkers, eventually leading to the covalent attachment of a cell
adhesive RGD containing peptide motif [20]. A variety of routes using aminosilanes for
further modification have been utilized. Examples are: 1.) an aminosilane reaction with
glutaraldehyde, which yields an aldehyde that can form an imine linkage with primary
amines on the peptides [21], or 2.) the reaction of aminosilanes with a mixture of peptides
and carbodiimides, which yields an amide linkage with carboxyl groups on the peptides
[15]. These two methods used primary amino groups and carboxyl groups that occur with
high frequency in peptides and proteins. However, specific peptide attachment at a
defined site was difficult to achieve due to the limited ability of the surface modification
technique to incorporate these functional linkages. Consequently, these approaches
produce unordered surfaces.
The surface modification of materials with peptides designed to mimic the
extracellular matrix of a nerve cell, have been used to couple peptides to polymeric
surfaces [22]. Poly(tetrafluroethylene-co-hexafluoropropylene) was first reduced with
sodium naphthalide to introduce surface carbon-carbon double bonds at two reaction
conditions: 20 min at -78C, and 3 h at 250C. Reduced poly(tetrafluroethylene-co-
hexafluoropropylene) film surfaces were further modified to introduce hydroxyl groups
via hydroboration/oxidation or carboxylic acid groups via oxidation. The hydroxyl (-OH)
and carboxylic acid (-COOH) functionalized surfaces provided reactive handles for
peptide coupling using tresyl chloride, eventually leading to the covalent attachment of 5-
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and 6-mers that promoted neurite extension [23]. Material scientists have designed and
synthesized surfaces that first resist protein adsorption and fouling, and then build back in
the chemistry to promote specific cellular interactions. This technology works for
polymers, like poly(ethylene glycol) (PEG), that resist protein binding. For example,
peptides containing the extracellular matrix binding domain RGD were incorporated into
mixtures of PEG diacrylate and acrylamidoyl peptides. The PEG diacrylate and
acrylamidoyl peptides were polymerized via photoinitiation [24]. Even though this
technique successfully linked peptides to PEG, it could not adequately control spatial
orientation of peptides on the material's surface, and it lacked the flexibility for
functionalizing the PEG surface with multiple biomolecules.
An additional method for cellular attachment involves the use of a combination of
Panacryl®, a poly(L-lactide-co-glycolide) resorbable material, and Pluronic®, a tri-block
copolymer consisting of a poly(propylene oxide) block sandwiched between two
poly(ethylene oxide) blocks 3DPT M patterned or solvent-cast to create a material that
supported cellular attachment. The polymer matrix materials were interacted with cells
to monitor adhesion. The findings of this research state that the 3DPTM patterned material
provided good cellular adhesion, through multiple entanglement processes, but state that
the cellular adhesion does not differ from that of solvent cast surfaces [18]. These
technique's, though novel, approach to patterning cells on surfaces provides non-specific
attachment of the cells to the poly(ethylene oxide). Although the poly(ethylene oxide)
layer is easily modified, it lacks the functional ability to prevent cellular aggregation
which would represent specific interaction with the surface.
15
The approaches outlined above do not meet the ideal criteria to create a surface
functionalized with a variety of biomolecule linkages. The strategy presented in the
current research is a different approach to functionalize a material's surface. The novel
methods of bacteriophage display of peptides and yeast surface display of scFv provides
the basic strategy to screen for peptide binding motifs that bind specifically to materials
with high affinity.
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CHAPTER 2: The Substrate: Chlorine-Doped Polypyrrole
2.1 Purpose
PPyC1 is an electrically conductive material that can be consistently deposited
onto a microscope slide. In addition, PPyC1 has been used as a substrate for nerve
regeneration in previous studies [2, 3]. This makes PPyC1 an ideal substrate for nerve
regeneration by modifying the surface of the polymer with peptides that can attach
biomolecules, or glial cells. As described previously, the focus of this work is to create a
surface that resembles a natural biological surface for the eventual incorporation into a
nerve guidance channel. PPyC1 peptides and/or antibodies attached to it's surface would
create a hybrid-biomaterial that could provide a specific link between a conductive
polymer and a biological surface, and thus surpass the effectiveness of the nerve autograft
for nerve regeneration.
2.2 Experimental Methods and Results
PPyC1 is a polycation with delocalized positive charges along its highly
conjugated backbone. The chloride ions provided charge neutrality when they were
incorporated as radical anions or "dopants". The PPyC1 film was electrochemically
deposited on indium tin oxide (ITO)-conductive borosilicate glass (Delta Technologies)
[25]. ITO glass slides were cleaned before use by sonication in hexane, methanol, and
dichloromethane for 5 min each. A three-electrode setup consisting of a saturated calomel
reference electrode, platinum gauze counter electrode, and an ITO slide as the working
electrode, was used for the electrochemical deposition of the PPyCl. The polymer was
deposited at a constant potential of 720 mV versus the saturated calomel reference from
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an aqueous solution of 0.1 M pyrrole monomer (Fisher Scientific) containing 0.1 M NaCI
(Fisher Scientific) providing the chloride ion as dopant. A Pine Instruments AFRDE5
bipotentiostat was used as the DC voltage source. Film thickness ranged from 150 nm-
200 jgm which was determined by integrating current over time, and was controlled by
the passage of charge based on the standard value of 50 mC/cm2 [25]. The charge
allowed to pass through the working electrode was measured with a current integrator
(IT001, Cypress Systems, Inc.) that was coupled to a multimeter (Sperry, DM-8A) for
digital display. The films were rinsed with Millipore water and stored in a desiccator for
two days before surface sterilization and sample interaction with either the bacteriophage
library or the yeast library.
The surface morphology of PPyCl was investigated using a scanning electron
microscope and an optical microscope for visualization of the microscopic surface that
individual bacteriophage and yeast would be screened against, Figure 2.1. The surface
has a characteristic "wrinkle" effect that is an effect of polymer thickness. Thus, with a
thinner sample thickness (< 10 gm) the "wrinkle" is less apparent.
The formation of the polymer is controlled by a radical cation polymerization
process and can be initiated and terminated by the introduction of charge into the system
[25]. From the chemical structure, Figure 2.2A, one can observe that the polymerization
process can proceed either at the a-carbon or the [-carbon. These two polymerization
points can form three different monomer linkages: a-a, a-PJ, or P-1. PPyCl monomer
linkages are usually constrained to the a-a. attachment and the a-pJ attachment because
of the lack of reactive polymerization sites. The a-a linkage is a linear attachment and
the a-3 linkage provides for some degree of branching to occur in the polymer. The
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linear polymer is formed by a-a linkages with two a-carbons bound, Figure 2.2B. The
branched polymer is formed by both a-a linkages, as described previously, and
a-3 linkages with an a-carbon and a 3-carbon bound, Figure 2.2C. The a-a polymer is
a much more conductive material because of its fully conjugated double bonds, which
provides an essential property for the electrical stimulation of cells for proliferation and
differentiation [26]. X-ray photoelectron spectroscopy (XPS) was used to chemically
characterize the surface of the polymer. High resolution XPS was able to resolve the Cl s
peak area from 292-282 eV, which can determine whether the monomers are linked either
by a-a linkages or a-J linkages. The Cls peak area represents the accumulation of
photoelectrons, produced by excitation of PPyCl by X-rays, which correlate in binding
energy to the carbon s electron shell. In the spectrum Figure 2.3, the a-a linkage is
centered on 284.5 eV and the a-pJ linkage is centered on 283.6 eV [27]. Based on this
data the linkages in PPyCl are mainly a-a linkages, which increases conductivity and are
consistent with previous studies [27, 28]. The XPS instrument used was a Physical
Electronics Phi ESCA 5700 equipped with an Al X-ray source (1,487 eV X-rays).
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Figure 2.1: Micrographs showing the surface topology of PPyCI . 2.1A-B) Scanning
electron micrographs with film thicknesses being 150-250 nm and 150-200 m,
respectively, 2.1 C) Optical micrographs film thickness: 5-10 pm, Scale bar = 50 jm.
2.2A N
p 
2.2B
'N N - N
2.2C / / 
Figure 2.2: 2.2A) Chemical structure of the pyrrole monomer, with a and P-carbons
labeled, 2.2B) Linear formation of polypyrrole, with a - a linkages, 2.2C) Branched
formation of polypyrrole, with a - a, a - J3, and P - P linkages.
20
1600-
1
1
1
aU
I
292 291 290 289 288 287 286 285 284 283 282
Binding Energy (eV)
Figure 2.3: C s core-line spectra for the 5-10 ~tm thick PPyCl film with characteristic a-
a carbon binding energy at 284.5 eV and a-p carbon binding energy at 283.6 eV.
To initiate the screening process, experiments analyzing the chemical makeup of
the substrate were needed. These experiments were used to determine if the screening of
such a material would be possible in aqueous solutions and give information regarding if
any deterioration would occur over the timescales used in either peptide or antibody
screens, which are on the order of 1.5 hour time span, and for in vitro cellular studies,
lasting up to 1 week.
The experiments consisted of placing recently electrically deposited, with in 24
hours, 0.5 cm2 samples of PPyCl in various solutions for varying time periods. Table 2.1
represents the solutions and time periods used for PPyCl degradation studies.
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Time PeriodSample Identification Solution Time Period
PPyCI none 0
PPyCI-TBS 1X Tris Buffered Saline (TBS) 1.5
PPyCI-SG SG-CAA 1.5
PPyCI Serum-free media (F12) 168
Table 2.1: Experimental parameters tested for substrate degradation. Select-Galactose
Casoamino Acids (SG-CAA).
From Table 2.1, the solutions used for interaction with PPyCl are the same as those
used for screening of peptides (TBS), antibodies (SG-CAA), and interaction with
mammalian cells (serum-free media, F-12, Invitrogen). The above experiments were
carried out in triplicate using the same larger sample of PPyCl cut to experimental
dimensions. Analysis of the above experiment was conducted using a Kratos AXIS Ultra
Imaging X-ray Photoelectron Spectrometer equipped with a monochromatic Al X-ray
source (1,487 eV) to determine the concentration of major and minor atomic components
of the substrate and using the various time periods to determine if there is degradation
over time in various solutions. Figure 2.4 represents this data with atomic concentration
ratios of C1 s, N1 s, Ols, and C12p. Macroscopically; there was no apparent degradation of
PPyCl in any of the solutions, which would have consisted of flaking and or dissolving.
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Chemical Analysis of Varing solutions with PPyCI
Figure 2.4: XPS chemical analysis of varying PPyCI samples.
Error bars = 1.38% (Cls), +0.70% (Nls), ±0.38% (Ols), +0.5% (C12p).
From the XPS atomic concentration ratio data there seems to be a general trend of
increased exposure to solution decreases the atomic concentration ratio of carbon, this is
evident by the gradual decline of the atomic concentration ratio of Cl s from a zero time
point to 1 week. Granted there is still approximately 80% of the original concentration
maintained after 1 week of interaction in solution. A possible reason for this decrease in
carbon's atomic ratio is the gradual increase in the oxygen atomic ratio over time, but this
increase is also media dependent. The oxygen atomic ration for the TBS sample is almost
doubled compared to PPyCl, but the use of SG-CAA for media interaction almost triples
the oxygen atomic ratio. The reason for these increases in oxygen atomic ratio can be
explained because PPyCl is an easily oxidized material and tends to do so when not
maintained with desiccant. Also of interest to note is the reduction in chlorine atomic
ratio in the films over a period of time, which is reduced from 9% to less than 1% in SG-
CAA containing media for 1.5 hrs. Understanding that the ratios are a percent
composition of the film explains this decrease in chlorine because of the increase in
23
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oxygen atomic ratio. From this data one can state that there is little loss of bulk material
with an increase in oxygen over a period of 1.5 hrs in all media types. Therefore the
increase in oxygen does not reduce the capabilities of screening the PPyCl film with
either peptides in TBS, antibodies in SG-CAA, or cells in F12 over the time period
needed for interactions.
2.3 Conclusions
Numerous polymeric materials have been used for tissue engineering applications.
PPyCl, being one of the many, was used for nerve regeneration studies and this work's
intention is to improve on the previous techniques used to modify polymeric materials by
biological selection of the polymer's surface. This provides experimental control on how
binding occurs. By electrochemical polymerization of the pyrrole monomer with a
chlorine ion as dopant, a chemical equivalent of the previously reported PPyCl was
produced [26]. Topographical characterization consisted of both scanning electron and
optical microscopy, with surface chemical characterization using XPS. Additional
information was extracted from the XPS data with the determination of the majority of
bonds between pyrrole monomers being a-a linkages. These a-a linkages create fully
conjugated double bonds along the backbone of polymer, which increases the polymers
conductivity compared to the a-5 linkages. The lack of degradation of the polymer was
also confirmed in TBS for peptides and in SG-CAA for antibodies to be insufficient to
deter continued experiments using the electrochemically deposited PPyCl. The data
shows that the polymeric material is consistent with previous work and will be used to
screen both peptides by bacteriophage display and antibodies by yeast surface display.
24
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CHAPTER 3: Peptide Selection of Chlorine-Doped Polypyrrole
3.1 Purpose
As previously described, the methods used for the surface modification of tissue
engineering applicable polymers have progressed significantly except in the area of
specific recognition towards the polymer's surface. By using a viral based combinatorial
display of peptides, one can selectively identify biological entities that specifically bind
the surface of the polymer of interest. This combinatorial selection process provides two
major advantages over the previous work performed: 1, the large number of experiments
that can be conducted simultaneously, up to one billion within the time frame of an hour.
This is advantageous to that of previous techniques which were limited to the monitoring
of only two or three different types of polymer modifications; 2, by controlling time and
pH of the interaction, one is able to selectively bind peptides that preferentially adhered
under these types of reaction conditions. Thus, one is able to identify specific peptides
that specifically bind peptides to the surface of a polymer, which can be further modified
with cellular binding domains such as RGD to create a bi-functional linking moiety.
3.2 Background of Bacteriophage Display of Peptides
Bacteriophage display of peptides, or phage display, is composed of viruses that
are genetically engineered to display 5-2700 copies random peptides per virion of a
specified length, on a portion of the virus' protein coat. This technique provides a very
flexible combinatorial approach and has traditionally been utilized for many applications
including antibody-antigen binding studies, mapping of protein-protein contacts, and
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identification of non-peptide ligands [29, 30]. Numerous researchers have taken
advantage of the versatility of the random peptide libraries displayed on phage to identify
bioactive peptides for immobilization of purified thrombin receptors and intact cells [31,
32]. Smith used the phage display technique to identify protease substrates by attaching
an affinity insert prior to the randomized region in order to separate cleaved from the
uncleaved phage [33]. Conversely, other investigators have used phage display to isolate
antibodies, hormones, and DNA binding proteins from their variants, using altered
affinity or specificity from libraries created from random mutant analogs [34]. A more
novel use of the phage display of peptides technique is used to determine a peptide
binding motif for a material to which nature has not had a chance to evolve such an
interaction. These types of attachments are being investigated for numerous materials
including semiconductors and metals such as gallium arsenide, cadmium sulfide, zinc
sulfide, and gold [35-40].
The phage display process has been applied to many substrates, ranging from
proteins to semiconductors, with successful identification of specific binding motifs.
This system is beneficial and unique for application purposes and the research in this
project addresses the ability to analyze numerous variants for a polymeric material, with
the eventual goal of specific surface engineering. Once material-specific peptides are
identified, any biomolecule, or cell, can potentially be immobilized and spatially
controlled for functionalizing biomaterials for tissue engineering applications.
The phage display of peptides uses genetic engineering to incorporate a random
amino acid sequence on the minor coat protein (pIII) of a filamentous virus, or
bacteriophage. Commercially-available libraries that have differing peptide lengths
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(twelve amino acid linear, seven amino acid linear, or seven amino acid constrained,
where cysteins are at the 1 t and 9 th position on the peptide to create a loop structure
through a disulfide bridge) on the pIII of the Ml 13 phage can be adapted for the screening
of numerous materials [36, 38]. The twelve amino acid linear peptide on the phage was
chosen because it was the longest of the peptide inserts, thereby providing the highest
variability of the commercially available libraries. After determining the polymer specific
peptide, the size of the peptide can be reduced to determine which amino acids are
significant to the binding of the peptide to the surface of the biomaterial.
3.2 Experimental Methods
The phage library was interacted after the PPyCl was synthesized (Chapter 2.2)
and samples cut into 0.5 cm2 segments and sterilized by submersion in 100% ethanol and
then dried in a laminar flow hood. The samples were then interacted with the phage
display library (Ph.D.-12TM Phage Display Peptide Library Kit, New England Biolabs)
for 1 hr at 25°C with medium rocking. The screening processing can be seen in Figure
3.1.
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Figure 3.1: Illustration of the selection process of peptides that recognize the surface of
PPyCl. On the right, E. coli was infected with phage to isolate individual phage clones for
sequencing.
An initial volume of 10 gl of phage-display library solution, corresponding to a
lx1012 phage/gl, was interacted with the PPyCl in lml of 0.1 M Tris-buffered saline
containing 0.1% vol:vol Tween-20 (0.1% TBS-T) pH 7.4. The library was incubated with
the PPyCl for 1 hr at room temperature. The PPyCl was then washed multiple times with
I ml of 0.1% TBS-T to discard non-specific phage. To disrupt binding of the phage that
successfully bound to the surface of the material, 500 [l1 of 0.2 M glycine-HCl pH 2.2
was added to the substrate (see pH elution Figure 3.1) for 10 min at room temperature.
The solution was collected and neutralized with Tris-HCl pH 9.13. Half of the volume of
the elution was then added to a 1:100 dilution of overnight culture of E. coli ER2837
bacteria (New England Biolabs) in LB media and was allowed to amplify in its bacterial
host to amplify for 4.5 to 5 hrs at 370C. The bacteria were removed from phage by
centrifugation at 14,000 rpm for 10 min at 40C. The phage were then precipitated with
poly(ethylene glycol) (PEG) for 15 min at 4C. The PEG-precipitated phage were
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pelleted by centrifugation at 10,000 rpm for 15 min. The phage were resuspended in 200
igl of TBS and saved as the amplification product.
The elution and amplification product were quantified by titering (infection into
bacterial host) serial dilutions on LB media plates. To achieve this ten fold serial
dilutions of the amplification product and the elution were prepared, 10 jgl of a serial
dilution was added to 185 gl of a mid log bacterial culture (Optical Density 600 nm= 0.5
OD/ml). The genetically engineered phage and infected bacteria, which posseses the lacZ
gene, were plated on LB plates with isopropylthio-p-D-galactoside (IPTG) and 5-Bromo-
4-chloro-3-hydroxyindolyl-,3-D-galactose (X-gal), producing P3-D-galactosidase that
hydrolyses X-gal forming an indigo-type blue-green precipitate. Thus, bacteria which
express the lacZ gene due to a phage infection event produce blue colonies when grown
in the presence of IPTG/X-gal were counted and used to determine phage concentration
(see plate Figure 3.1).
The phage concentration from the titer of the amplification was used to determine
the input of the next round of biopanning against the material. A fresh piece of PPyCl
was used for the next sub-set of library screening with input of phage -109 virons.
Interaction, washing, isolation, and amplification were repeated as described above. The
process was continued until five rounds of selection were completed. After 3 rd to the 5 th
round of biopanning, blue colonies plated during titering were picked with a tooth pick
and amplified individually for 5 hr in 1:100 an overnight culture of E. coli in LB media
(1 ml) to produce DNA to send for sequencing. The bacteria were separated from phage
by centrifugation for 30 sec at 14,000 rpm. 500 gl of the phage solution were PEG-
precipitated for 10 min at room temperature and then pelleted by centrifugation for 10
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min at 14,000 rpm. The phage pellet was suspended in a 100 gl solution of 4 M sodium
iodide to rupture the phage protein coat. DNA from the phage was precipitated with 250
,gl of 100% ethanol. The precipitated DNA was then suspended in 30 gl sterile Millipore
water. Nucleotide sequences from the phage DNA were obtained from The Institute for
Cellular and Molecular Biology DNA Core Facility (The University of Texas, Austin,
TX) and then translated into N-terminus to C-terminus peptide sequences.
After PPyCl was screened, the peptide sequences deciphered from nucleic acid
sequences were analyzed for a predominant or consensus sequence, in order to determine
a preferential binding motif for the polymer. Subsequent studies are centered on this
selected peptide that was specifically chosen for PPyCl under controlled conditions.
An amplification of individual clones was performed to verify that the clones did
not preferentially amplify better than other clones due to the screening process. This
experiment consisted of re-amplifying the corresponding phage containing the selected
peptides, as described previously. The titer counts of the T59 were compared to the
amplification of the other phage selected from the screening process (T36, T45) and WT,
to verify that the peptides were not selected because of their amplification ability. Results
are shown in Figure 3.3.
The quantification of phage clones bound to the surface of PPyCl consisted of
both titering and immunolableing. The titering of the binding clones consisted of
interacting 1x108 virons per clone (T59, T36, T45, WT) with ethanol sterilized 0.5 cm2
samples of PPyCl in 1 ml TBS for 1 hr at room temperature with medium rocking. The
samples were then washed three times with 1 ml of 0.1% TBS-T to remove any unbound
phage. Elution of bound phage with 500 gl 0.2 M glycine-HCl pH 2.2 for 10 min was
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used to isolate phage bound to the surface. This suspension was then neutralized with 150
ml Tris-HC1 pH 9.1 and stored as elution. The elution's of the phage clones was then
titered to determine the concentration of the recovered phage and these clones were
sequenced again to determine the abundance of clones from the interaction. The
experiment was conducted in triplicate with 34 clones selected from the first sample and
33 clones from the second and third samples to total 100 clones. Results are shown in
Figure 3.4.
The immunolableing of phage clones bound to PPyCl consisted of interacting a
phage concentration of lx10 4 virons/gl with 0.5 cm2 sample of PPyC1 for 1 hr, to allow
the phage to bind to the surface. The samples of PPyC1 were then washed three times
with 1 ml of 0.1% TBS-T, to remove any unbound phage from the surface of PPyCl. The
samples were then interacted with the biotinylated primary anti-body (Sigma-Aldrich), at
a dilution of 1:400 antibody to 4% Bovine Serum Albumin (BSA) in TBS pH 7.5, for 1
hr at room temperature. The samples were washed twice with 1 ml of TBS pH 7.5.
Samples were interacted with the fluorescein-labeled-streptavidin (Exaplha), at a dilution
of 1:200 fluorescein-streptavidin to 4% BSA in TBS pH 7.5, for 30 min at room
temperature in the dark. Samples were washed twice with 1 ml of TBS pH 7.5. The
samples were mounted on microscope slides (Fisher Scientific) and imaged. The samples
were imaged using a Leica TCS 4D confocal microscope equipped with differential
interference contrast optics and a Kr/Ar mixed gas laser with a selected excitation
wavelength of 488 nm for fluorescein and emission at 520 nm was collected through a
40X oil immersion objective (Microscopy Laboratory of the Institute for Cellular and
Molecular Biology, University of Texas, Austin, TX). Results are shown in Figure 3.5.
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3.3 Results
Sequences were obtained from the clones selected after each subsequent screen
following the 3 rd round. Results from the study for screening PPyCl rounds three through five
are illustrated in Figure 3.2.
T36
T43
T59 (24X)
Ma-ILK
_T.P F W3E
Figure 3.2: Peptide sequences from selection rounds three through five obtained from PPyCI-
specific phage. The single letter code for the 20 amino acids was used in depicting the peptide
sequence. The color coding corresponds to the amino acid group: Basic-blue (lysine, histidine,
arginine); Acidic-red (aspartic acid, glutamic acid); Hydrophobic-orange (glycine,
alanine., valine, leucine, isoleucine); Hydroxyl-green (serine, tyrosine, threonine);
Aromatic-brown (phenylalanine, tryptophan); Amines-purple (asparagine, glutamine),
Methionine-white, Proline-yellow
From Figure 3.2 it is apparent that the predominant sequence is that of T59 by an
overwhelming margin of 92% to both the other clones. It is interesting to note that the
increase in hydroxyls and lack of prolines amino acid groups were significantly different
in comparison to the combinatorial peptide library reported values for these groups
(Selected Peptides: hydroxyl = 41.0% and proline = 1.0%; Library: hydroxyl = 24.7%
and proline -= 12.2%). Note that the polymer backbone of PPyCl has alternating
secondary amines on adjacent pyrrole monomers making the overall polymeric charge
somewhat positive (Figure 3.2). One possible scenario for the increase in hydroxyl
groups in the peptide is an amide interaction that could occur between these two
functional groups at the surface of the material. The rigid structure that is created from
the influence of proline may increase the probability of conformational alterations to the
twelve-mer peptide which could increase the peptide's binding capability. These types of
interactions, electrostatic and secondary structure presentations, which commonly occur
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between proteins, may play an integral role in the binding of the predominant sequence to
conductive PPyCl.
3.3.1 Amplification of Phage Selected for Chlorine-Doped Polypyrrole
A good understanding of how the phage amplify in their bacterial host is needed
to confirm that the predominant sequence selected for the PPyCl surface was specific for
the material and not chosen for the phage's ability to amplify in its bacterial host. This
can be a concern because of the multiple rounds of selection/bacteriological infection that
the phage undergoes in the selection process. If predominant phage multiply better than
naturally occurring wild type (WT) phage, which has no engineered peptide insert, then
there is a possibility that the phage containing the predominant sequence peptide was
selected because of its ability to amplify and not because of its specific binding ability to
the surface of PPyCl.
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Figure 3.3: Amplification study of phage selected for PPyCl, Error bars = ±5%.
T59: THRTSTLDYFVI; T36: TIKMHTLSYTGL; T43: SHKYPKPPYFHW; WT: NA
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The similarities between the phage concentrations after amplification are
sufficient to determine that they are within 5% of each other. From Figure 3.3 T59, T36,
T43 and WT amplify to the same order of magnitude under the conditions described. The
similarities in the amplification of the different phage demonstrate that T59 was not
selected because of its increased ability to amplify.
3.3.2 Binding Ability of Phage Selected for Chlorine-Doped Polypyrrole
To investigate whether the predominant viral-bound peptide binds specifically to
the PPyCl surface, the binding ability of the peptide was investigated using two methods:
phage concentration (titering) and immunolabeling of phage. The concentration of phage
bound to PPyCl was determined using a titer count which is semi-quantitative and
provides a relative binding comparison of phage counts for each of the clones selected
from the screen and WT.
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Figure 3.4: Competitive binding study of phage selected for PPyCI, Error bars = ±5%.
T59: THRTSTLDYFVI; T36: TIKMHTLSYTGL; T43: SHKYPKPPYFHW; WT: NA.
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This study was performed to compare the competitive binding ability of T59, T36,
T43, and WT by comparing the amount of phage that could be recovered from the surface
of PPyCl. The titer count method of binding ability of PPyCl shows that T59 binds more
successfully than other types of phage tested. T36, T43, and WT had minimal recovery
most likely due to non-specific interactions with the surface of PPyCl as can be seen by
the recovery of a single WT clone. T59 has the greatest recovery rate of phage bound to
the surface with 94 clones out of 100. This result verifies the ability of T59 phage clone
to bind to PPyCl through its unique minor coat protein, pIII, since all of the other clones
have identical major coat proteins, pVIII. This is initial encouraging data showing that
T59 is specific to the polymer surface.
Immunolableing of phage particles was used to fluorescently label the phage
bound to the surface of the PPyCl, permitting quantification of phage bound to the PPyC1.
A biotinylated antibody was used to bind to the M13 bacteriophage, specifically on the
pVIII protein of the virus (Sigma-Aldrich Corp.). The biotin end of the antibody afforded
attachment of a streptavidin labeled fluorescein (Exaplha) to visualize the phage on the
polymer using fluorescence microscopy.
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Figure 3.5: 3.5A) Reflectance image of PPyCl-with phage, 3.5B) T59-1 0-2° ,
3.5C) random phage-l1-2 0 , 3.5D) WT-10 -20, 3.5E) 1°-2° , 3.5F) 20, 3.5G) mounting media.
Scale bar = 50 m. 1 = primary antibody (anti-MI3-biotin), 2 = secondary antibody
(streptavidin-fluoroscein). T59: THRTSTLDYFVI; Random sequence: IEHPKTPDSHSR
From Figure 3.5B due to high fluorescent signals T59 was shown to have specific
interaction with the PPyCl surface. The intensity of the fluorescein emission at 520 nm is
monitored on all samples for comparative purposes. Through Figures 3.5B-G the greatest
intensity is that of T59, further confirming T59's specificity for PPyCl. Random phage
and WT were used as controls to verify T59's binding specificity. The viral bound
peptides on the random clone and WT were different than that of the peptide sequence
displayed on T59 and also have lower fluorescence intensity, suggesting that the T59
phage bind specifically to PPyCl. When Figure 3.5B (T59) and 3.5D (WT) are compared
the PPyCl specific phage showed a difference in both coverage and intensity in favor of
the T59 clone. This intensity difference may represent WT non-specific phage interaction
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occurring at the PPyCl surface. The WT phage is the naturally occurring phage and the
pIll coat protein of the WT phage has not undergone genetic engineering. Therefore the
only difference between T59 and WT phage is the pll peptide insert on T59. The
increased intensity for the T59 compared to WT is therefore likely due to the interaction
that occurs between the engineered peptide on T59 and the surface of PPyCl. From
Figures 3.5E-G, that the amount of fluorescence from the antibody, streptavidin labeled
fluorescein, and mounting media is minimal compared to the intensity of labeled phage.
All samples were imaged using the same intensity of laser light and exposure times,
except for the reflectance image (Fig. 3.5A) which was not imaged with the laser but with
a 100 W Hg lamp.
3.4 Conclusions
Extensive screening processes have been performed to obtain the best binding
peptide under controlled conditions. After selecting the phage that displays the peptide
that binds specifically to PPyCl, the phage containing the engineered peptide of interest
was confirmed to not be selected as a result of amplification bias in its bacterial host. A
better understanding of how well the T59 phage binds to the surface was further
investigated. In the competitive binding comparison, T59 had a much higher population
compared to that of other clones selected from the screen as well as WT which verifies
that T59 is best binding peptide for PPyCl under controlled conditions analyzed so far.
To confirm that we had found the best binding peptide, a second comparative binding
assay was performed investigating actual phage bound to the surface of the conductive
polymer. Through the use of immunolabeling, the phage were visualized by fluorescence
microscopy bound specifically to the surface of the conductive polymer. The
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immunolabe]ing experiments further reconfirmed what was observed from competitive
binding comparison. Thus, the T59 peptide sequence of THRTSTLDYFVI has the best
binding ability to the conductive polymer PPyCl while in neutral pH buffer at room
temperature, binding that can be disrupted with an acid elution.
Eventually peptide connections that are being made between the surface of a
material and a peptide will play an integral role in the modification of surface binding.
Ultimately one will be able to spatially control peptide incorporation onto a hybrid-
biomaterial providing a bi-functional linker for attachment to cells, such as Schwaan
cells, and biomolecules (nerve growth factor) along with the -50% increase in nerve
regeneration associated with electrical stimulation, all of which have been shown to
regenerate nerve cells on their own [3, 11, 41, 42]. This type of integration of peptides
and materials will further expand the possibilities of the tissue engineering industry. This
interface of materials science with biology, will allow the tailoring of properties that are
needed in biomedical materials such as degradation rate, surface area, and immunogenic
response, and the exploitation of natural biological processes leading to new and exciting
research. Starting with a material such as PPyCl that has already undergone extensive
investigation for the regeneration of nerve tissue one can modify the surface of this
material, by using phage display to isolate and identify specific peptides that recognize
the surface of PPyCl, and presumably construct a "hybrid-biomaterial."
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Chapter 4: T59 Binding Mechanism Using Peptide Analogs
4.1 Purpose
The T59 peptide expressed on the PPyCl-specific phage has been shown to bind
specifically to the surface of PPyCl. From the T59 peptide amino acid composition, there
are several reasons to explain the interaction with the polymeric surface. For instance,
from looking at the sequences and comparing the experimental values of amino acids in
the peptide to the literature values of expected populations, as reported in the previous
chapter it was determined that there was an increase in the presence of hydroxyl groups
by 16.3% compared to the literature value. This increase could possibly be because of
potential hydroxyl-amide interaction at the surface of the material. Here, to elucidate how
T59 binds to PPyCl, substitutions in the T59 peptide sequence were made to create
peptide variants. By studying the interactions of these variants, aspects of the peptide can
be verified for the importance in binding to the polymer.
Protein concentration assays were used to evaluate the proposed peptide variants
binding to the surface of PPyCl. Most protein assays are simply colorimetric and are
comprised of a signal molecule for detection. A list of colorimetric protein concentration
assays used in the literature are shown for comparison in Table 4.1.
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Assay Dynamic range Time Advantages Disadvantages
UV 10 ug/ml-50 g/ml none Low cost, nondestructive, Sensitivity depends on the number
or 50 jig/ml-2 well established of tyrosine and tryptophan residues
mg/mi procedure present
Lowry 1 ,ug/ml-1.5 mg/ml 1.5 hrs Well established Lengthy procedure, not compaitble
procedure, little protein to with surfactants or reducing agents
protein differences
Bradford 1 gg/ml-1.5 mg/ml 30 Well established Not compatible with surfactants,
minutes procedure, useful when high protein to protein variations
accuracy is not crucial
OPA 200 ng/ml-25 5 Compatible with aqueous Not comaptible with Tris or
gg/ml minutes solutions glycine buffers
BCA 500 ng/ml-1.2 1-1.5 hr Compatible with Certain amino acids can interfere
mg/ml surfactants
NanoOrange 10 ng/ml-10 gig/ml I hr Little protein to protein Not a well established assay
differences
Fluorescamine 100 ng/ml-200 I Well established Not compatible with aqueous
gg/ml minute procedure, unbound dye solutions
is nonfluorescent
Table 4.1: Table of protein assays there dynamic range, assay time, advantages and
disadvantages.
For the work that was performed, the assay to be used needs to be an established
method that has a dynamic range of nM to gM concentration regimes and has a limited
amount of incubation time for high throughput. Therefore, the technique that was selected
was the fluorescamine assay, because it has been well established, lacks the incubation
time required from the others and the dynamic range is with the limits necessary for
detection of peptides on PPyC1. An additional benefit from the use of this technique is
that it is a fluorescence technique; therefore the opaque surface of PPyCl should not give
significant background fluorescence.
Most protein assays are based on the conversion of reagents to products with
characteristic absorption spectra which correlate to relative protein concentrations.
Fluorescamine, spiro(furan-2(3H), 1 '(3'H)-isobenzofuran)-3,3'-dione, 4-phenyl, is an
intrinsically nonfluorescent molecule but it reacts in milliseconds with primary aliphatic
amines, including peptides and proteins, to yield a fluorescent derivative, Figure 4.1 [43].
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The amine-reactive reagent has been shown to be useful for determining protein
concentrations of aqueous solutions and is well suited for a fluorescence microplate
reader [44-47]. Additionally, the reaction with fluorescamine proceeds efficiently at
room temperature in aqueous solution, with the half-time of the reaction of 200-500 msec
at pH 9.0, for most amino acids, with excess reagent concomitantly hydrolyzed allowing
the assay of submicromolar concentrations of amines.
)H
+ R-NH2
Figure 4.1: Fluorescamine reacts with primary aliphatic amines to form a pyrrolinone
that fluoresces at 475-490 nm with excitation at 390 nm.
4.2 Experimental Methods
Substitutions in the T59 peptide were made strategically to remove/replace
reactive groups that could be responsible for the peptide binding to PPyCl. Specific
substitutions were as follow: the amino acid composition of T59 was reversed to
determine if amino acid order plays a role in binding; reduced to half to negate half of the
amino acids in the peptide on both the N-terminus and C-terminus; halves reversed to
reduce amino acid content and determine if order plays a role in binding; reduced to half
with glycine spacer to determine if the reduced amino acids played a role in binding but
require a better secondary structure supplied by an extended peptide; histidine (H) and
arginine (R) replaced with serine to determine if HR plays a role in binding and how
serines influence binding; HR replaced with glycine to determine if HR plays a role in
binding and how glycines influence binding; HR replaced with aspartic acid (D) to
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determine if HR plays a role in binding and how aspartic acids influence binding; D
replaced with R to determine what role D plays in binding and how R influences binding
in this area of the peptide; D replaced with glycine to determine what role D plays in
binding and how glycine influences binding; HRD replaced with glycine to determine if a
complete substitution of the charged reactive groups in the peptide has an influence on
binding to the polymeric surface; front half of T59 with HR replaced with glycine to
determine if the lack of charged groups in the front half is sufficient for binding; front
half of T59 reversed with HR replaced with glycine and a glycine spacer to complete the
12-mer to determine if structure, order, and lack of charge play a role in binding; in the
front half replace HR with tyrosine (Y) and phenalanine (F); and in the back half replace
YF with HR to determine if order of the amino acids play a role in binding the surface of
PPyCl. All variants are shown in Table 4.2.
T59 THRTSTLDYFVI
T59R IVFYDLTSTRHT
F6 THRTST
B6 LDYFVI
F6R TSTRHT
B6R IVFYDL
F6G THRTSTGGGGGG
B6G LDYFVIGGGGGG
F6RG TSTRHTGGGGGG
B6RG IVFYDLGGGGGG
HR/S TSSTSTLDYFVI
HR/G TGGTSTLDYFVI
HR/D TDDTSTLDYFVI
D/R THRTSTLRYFVI
D/G THRTSTLGYFVI
HRD/G TGGTSTLGYFVI
F6HR/G TGGTST
F6RHR/GG TSTGGTGGGGGG
HR-YF TYFTSTLDHRVI
Table 4.2: Strategic amino acid substitutions in the T59 peptide. Right column: variant
label, Left column: single letter amino acid peptide sequence.
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The above sequences were fabricated on an ABIMED peptide arrayer system
consisting of a computer controlled Gilson diluter and XYZ liquid handling robot
(Biopolymers Lab, MIT) and purified to 95% by HPLC. The peptide variants were
interacted with a sterilized 0.5 cm2 sample of PPyCl at concentrations ranging from 0-15
ptM in 1X PBS for 1 hr at room temperature. Standard curve concentrations of T59
peptide ranged from 0-15 RM to determine actual peptide concentrations on the surface of
PPyCl. The above samples were washed three times with 1X PBS and rehydrated with
300 gl1 of 1X PBS. One minute before reading the samples emission at 480 nm (excitation
at 390 nm), 100 tl of 1.79 mM fluorescamine in acetone was added to label peptides
bound to PPyCl. All experiments were repeated in triplicate. Emission readings were
taken on a Gemini XPS system controlled by SoftMax Pro® software.
4.3 Results
Sub-sets of the above modifications to T59 were screened against the surface to
better understand the potential of a 12-mer peptide and a 6-mer peptide. The first of the
interactions consisted of the following modifications to the T59 peptide: T59, T59R,
F6G, B6G, B6RG, B6RD/GG, and HR/G.
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Figure 4.2: Surface concentration of peptides interacted with PPyCI. Error bars = I±1 SD.
From Figure 4.2, the data shows that peptides that do not contain the aspartic acid
(D) residue have little binding capability to PPyCl. Additionally, all other peptides
containing D bind within a standard deviation of each other.
To determine if peptide variants bind with higher affinity to PPyCl than the T59
peptide, the same procedure was used as before by interacting peptide variants with
PPyC1 samples, then washing and labeling bound peptides with fluorescamine. The D/G
variant was used along with T59, F6G, B6G, and B6R.
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Figure 4.3: Peptide variants binding compared to T59 peptide at 15 gM.
Error bars = percent deviation.
For data analysis of this study, peptide variant surface concentrations were
compared to the T59 surface concentration and converted to a percent of T59 surface
concentration. From the above data it is shown that both F6G and D/G, which lack D in
their amino acid composition, bind significantly less than that of T59. B6G and B6R,
which contain D, have increases in binding compared to T59, with B6G having a
significant increase of almost 1.5 times more surface concentration compared to that of
T59. Ultimately, Figure 4.3 reiterates the conclusion that was drawn about the data from
Figure 4.2, that the role of aspartic acid is playing an essential role in binding T59 to
PPyCl.
The initial phage screening was performed at pH 7.4 with elution or release of the
binding phage at pH 2.2. The pKa of the reactive groups in T59 (H, R, D, Y), are 6.04,
12.48, 3.90, and 10.46, respectively [48]. From the pKa values it is apparent that the only
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species that would protonate at the release pH would be that of the 3-COO- of the
aspartic acid. The previous experiments concerning the use of T59 peptide variants have
hinted that aspartic acid plays a significant role in binding T59 to PPyCl. To test this
hypothesis, a binding assay was conducted where a change of pH is involved. The
experiment was performed by interacting the same concentration range of 0-15 gM of
T59 peptide with samples of PPyCl in 1X PBS adjusted to a pH of 2, 4, 6, 7.4, and 8. The
data is shown in Figure 4.4 with input concentrations on the ordinate and peptide surface
concentration on the abscissa. From the data represented by the change in pH over the
scale of 2-8 that is used for screening, it was observed that the binding of the T59 peptide
above that of a pH 2 all follow the same trend of increased binding with increased input
concentration. As for T59 binding in pH 2 PBS it is significantly less than that of all other
pH ranges.
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Figure 4.4: T59 peptide binding comparison in differing pHs. Error bars = ±1I SD.
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If one evaluates this scenario on a molecular scale, the aspartic acid reactive
group -COO- is being protonated at a pH below 3.86 to -COOH, thus thereby
disrupting the binding between the negatively charged residue and the positively charged
surface of PPyCl.
To better understand what it takes to bind to PPyCl, an additional set of clones
was created that only represented the last six amino acids of the T59 peptide. This
grouping was selected because of its ability to bind to PPyCl, as seen in Table 4.3 clones
(B6G and B6R). This additional set of clones focused in on the ability of aspartic acid to
mediate peptide binding to PPyCl with strategic replacements of aspartic acid with
glutamic acid and asparagine. To determine if any of the adjacent residues have a minor
role in binding to PPyCl, they were replaced sequentially from N-terminus to C-terminus
and vice-versa with alanine. An alternative clone with two aspartic acids centrally located
in the peptide with two flanking alanines on both sides was also synthesized to determine
if there is an increase in binding to PPyCl with an increase in aspartic acid residues. The
above mentioned clones are represented graphically by their single letter amino acid code
in Table 4.3.
B6 LDYFVI
B6E LDYFVI
B6N LDYFVI
A8-12 ADYFVI
AO1-12 ADAFVI
Al 1-12 ADAAVI
A12 ADAAAI
A7-11 LDYFVA
A7-10 LDYFAA
A7-9 LDYAAA
A7-8 LDAAAA
AD ADAAAA
DD AADDAA
Table 4.3: Amino acid substitutions of the last six residues of the T59 peptide.
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As shown previously with the fluorescamine assay of the T59 clone binding to
PPyCl, these peptide variants were assayed and their results are as follows in the Figure
4.5.
4.5A T59 back six acidic versus basic
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Figure 4.5: T59 back six amino acid variant clone fluorescamine binding assay.
4.5A) Acidic/Basic comparison, 4.5B) Alanine substitutions. Error bars = +1 SD.
The comparison of acidic and basic residue alterations to the back six of the T59
peptide shows that when the aspartic acid residue was replaced with glutamic acid (B6E)
there was very little change in binding capacity of the peptide variant, but when the
aspartic acid was replaced with asparagine (B6N) there was a significant decrease in the
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binding capability of the peptide to PPyCl. This suggests that the acidic residues, aspartic
acid and glutamic acid, are interchangeable when incorporated into this peptide and that
the lack of a carboxylate reactive group significantly reduces the binding of the peptide to
PPyCl supporting the hypothesis that when protonation occurs with aspartic acid and
glutamic acid around a pH of 4 the peptide releases from the surface of PPyCl.
Figure 4.5B represents the evaluation of the binding of various alanine
substitutions made in the back six amino acids of the T59 peptide. From this data some
surprising conclusions can be drawn. When alanine replaces leucine (A8-12), which is
directly adjacent to the aspartic acid residue, there is slight reduction in binding compared
to the full back six (B6). When alanine replaces leucine and tyrosine (A10-12) there is a
significant decrease in binding and secondarily (A 1-12, A12, AD), suggesting there is
some secondary importance to both leucine and tyrosine being adjacent to aspartic acid
within the peptide. This is reconfirmed when the alanine replaces the last three residues
of the peptide leaving only leucine, aspartic acid, and tyrosine (A7-9). As can be seen in
the graphical analysis the A7-9 clone is the only clone of all 13 back six clones to bind at
least half of the input concentration, reaching 10.61+0.53 gM. Other alanine substituted
clones A7- 1, A7-10, and A7-8 lead to the same conclusion of the secondary importance
of adjacent leucine and tyrosine to aspartic acid. The DD clone provided some very
interesting binding data suggesting that without either leucine or tyrosine adjacent to
aspartic acid there can still be some binding to PPyCl by increasing the number of
aspartic acid residues in the peptide.
50
4.4 Conclusions
T59 peptide and its variants were evaluated using a fluorescamine assay by
interacting known concentrations of the peptide variant with 0.5 cm2 samples of PPyCl,
washing the samples, and labeling the remaining peptide bound to PPyCl. Initial
experiments alluded to the premise that the charged species, aspartic acid, could play a
significant role in peptide binding to PPyCl. Further variants reinforced this idea, cued
from the initial work that residues with higher aspartic acid occurrence, bound to PPyCl
more significantly than the T59 peptide. This data revealed the possibility that the
complete T59 peptide need not be present for binding to PPyCl, specifically the front six
amino acids. However, without aspartic acid binding was drastically reduced revealing its
necessity. The variant B6G had the best relative binding to PPyCl which when compared
to B6R; this confirms secondary structure is also important for good binding, because
these two variants differ only by a glycine spacer. The validity of this statement is
represented by the increase in binding with B6G at 1.5 more and with B6R at 1/3 more
than the full T59 peptide.
To determine the pH sensitivity of the T59 peptide, differing pHs, ranging from
2-8 were evaluated. These results revealed that, at pH 2, T59 binds significantly less than
all other pH values attempted. This data confirms the function of aspartic acid in T59
binding of PPyCl, by protonating the reactive carboxylate group at pH 2 the binding is
greatly reduced. Thus, the data from these experiments suggests that the binding of the
T59 peptide is dependent on the interaction of negatively charged residue, aspartic acid,
with the surface of positively charged surface of PPyC1 and not the hydroxyl groups
making amide bounds with the surface as previously hypothesized. This interaction
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suggests that the mechanism for binding is a shared hydrogen between that of aspartic
acid and certain areas of the polymer.
Working off of the hypothesis that the last six amino acids contain the residues
responsible for binding T59 to PPyCl, other peptide variants were made with strategic
sequential alanine substitutions. This permitted the evaluation of binding of an individual
or groups of amino acids in the peptide. From this data it was determined that aspartic
acid can be replaced with glutamic acid with little decrease in binding capability. This
lack of difference in binding is most likely due to glutamic acid's similar pKa of 4.07
compared to aspartic acid's pK, of 3.86. When a basic residue replaced aspartic acid there
was a significant decrease in binding, suggesting that an acidic residue is necessary for
the peptide to bind to PPyCl. The sequential alanine substitutions provided insight in to
possible secondary residues necessary for binding. From the findings it appears that
having leucine and tyrosine adjacent to aspartic acid is essential to binding PPyCl
represented by an increase in binding capability. Finally, using multiple aspartic acids in
the peptide showed a similar binding capability as the full back six at 15 gM input
concentration.
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Chapter 5: Peptide Functionalization of the Chlorine-Doped Polypyrrole
5.1 Purpose
To show proof of concept for a nerve guidance scaffold, where by nerve cells are
specifically attached to the surface of the scaffold through a biological tether, one needs
to group together the necessary components. These components consist of the scaffold
material, the biological bi-functional linker, and nerve cells that have been used as a
model system for in vitro system evaluation. The components for the system described
here are comprised of 5-10 ,gm thick PPyC1, a T59 peptide that has been modified on the
C-terminus with a spacer GGSK, a cell adhesion promoting heptmer peptide GRGDS,
and model neuronal cells from rat. These components will be used to create a single unit
bi-functional linker between a neuronal scaffold and cells that in the presence of nerve
growth factor will differentiate, producing axon processes.
5.2 Experimental Methods and Results
The T59 peptide was modified with a spacer GGSK at the C-terminus and a cell
adhesion promoting sequence GRGDS linked to the spacer producing a single letter
amino acid sequence of THRTSTLDYFVIGGSKGRGDS (T59-GRGDS) (Institute of
Cellular and Molecular Biology Core Facilities, University of Texas at Austin). The
peptide was purified to >99% by HPLC by the manufacturer.
Initial studies focused on the optimizing the input concentration of T59-GRGDS.
As previously described, these studies were conducted using the fluorescamine assay
with T59-GRGDS peptide as the standard curve peptide. The studies were carried out by
53
interacting knows concentrations of T59-GRGDS (0-60 M) in 1X PBS with ethanol
sterilized PPyCl 0.5 cm2 samples for 1 hr with medium rocking. The samples were then
washed three times with 1 ml for 5 min with subsequent labeling of bound peptide using
fluorescamine and then assayed as described previously in Chapter 4. The experiment
was conducted in triplicate and the data is represented in Figure 5.1.
T59-GRGDS Binding to PPyCI
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Figure 5.1: T59-GRGDS input optimization. Error bars = ±1 SD.
From the above data one can observe that there is a gradual rise in surface
concentration as the input concentration is increased up until the input concentration of
15 M. At 15 jiM it seems that the PPyCl surface has been saturated with T59-GRGDS.
This is evident because as the input concentration is increased further to 30 M and
60 gIM the actual surface concentration remains within 1 SD of the 15 jiM surface
concentration. This suggests that at an input concentration of 15 jiM or higher all of the
binding sites on a 0.5 cm2 sample of PPyCl are occupied by peptides. Therefore, for
further studies an input concentration of 15 jiM will be used to saturate the PPyCl surface
with the bi-functional peptide T59-GRGDS.
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As well as determining the optimal input concentration of bi-functional peptide, it
would also be of interest to note for what period of time is T59-GRGDS bound to the
surface of PPyCl in the presence of cellular media. This would give an idea as to what is
influencing the binding of cells from one hour to one month. To perform such an
experiment, an input concentration of 15 M of T59-GRGDS peptide was used per the
previous experiment, to saturate the surface of PPyCl. The time points for the experiment
were taken at 1 hour, 3 hours, 1 week, and 1 month, and were conducted in triplicate in
both serum-free and serum-containing media. In the serum containing experiment,
controls of serum only samples were used to obtain quantity of bound T59-GRGDS. The
PPyCl samples were sterilized as previously described prior to interaction with the
respective media. Figure 5.2 represents these set of experiments.
Figure 5.2: Serum dependent study of T59-GRGDS peptide bound to PPyC over
varying time points. Error bars = ±1 SD.
As the above data suggests there was little change in surface concentration of
T59-GRGDS in both serum and serum-free media. Quantitatively, over a period of 1 hr,
there was a decrease in peptide concentration by 3.7% and 1.2% for serum and serum-
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free media, respectively. A significant deviation between serum and serum-free peptide
concentration becomes evident at a period of 7 days, when the difference between them is
18.5%. This most likely occurs because the serum is displacing the peptide on the surface
of PPyCl. This displacement is even more apparent after a period of 1 month when the
percent decrease of T59-GRGDS bound to the surface of PPyCl is 26.0% and 20.2% in
serum and serum free media. But more importantly from the experiments conducted, it
was determined that the overall reduction in T59-GRGDS concentration on the surface of
PPyC1 is at most reduced to 74.0% and at least to 79.8% of the original bound peptide in
serum-containing and serum-free media over a period of 1 month, respectively. When
these values are compared to that of varying surface concentrations in Figure 5.1, we see
that most of these values could represent, when bound to the surface of PPyCl, an input
concentration of 4.4 gM which represents 1.32x1015 peptides/mm 2 which is still a
significant number of peptides to have available for adhesion to cells.
For the cellular studies, PPyCl samples were prepared by sealing plexi-glass wells
(1.5 cm x 1.0 cm x 1.0 cm) using silicone rubber sealant (DAP, Inc.) onto PPyCl thin
films prepared on ITO-coated glass slides which was allowed to cure overnight. The
samples were washed three times with 1X PBS and ethanol sterilized for 30 min. The
samples were rinsed three times with 1X PBS prior to peptide incubation and maintained
in sterile environment continuously. Incubation of 15 M T59-GRGDS peptide on 0.5
cm2 PPyCl samples for 1 hr in 1X PBS at room temperature was followed by thorough
rinsing three times with 1X PBS to remove any unbound peptide.
The cells used were a neuronal, PC12, rat phenochromocytoma cell line that
responds to nerve growth factor (NGF) by expressing 'neurite-like' processes, which
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were purchased from the American Type Culture Collection. PC 12 cells were cultured in
85% F-12 media supplemented with 10 mM 4-(2-hydroxyethyl) piperazine-1-
ethanesulfonic acid, 25 mM glucose, 1 mM sodium pyruvate, 10% horse serum, and
5% fetal bovine serum and plated onto collagen coated flasks. Cells were maintained at
37C in a humidified 5% CO2 incubator. Media was replaced every 2-3 days, and cells
were passed with 2.5 mM trypsin/1 mM ethylene-diaminetetraacetic acid.
PC12 cells were seeded onto PPyCl or PPyC1 with T59-GRGDS peptide in
serum-free and serum-containing media at a density of 104 cells/cm 2 and were allowed to
attach at 370C in 5% CO2, overnight. Cell growth media was removed from the samples
each day and then replaced with fresh media after rinsing the substrates once with 1X
PBS for a total of 3 days. At the end of the third day (72 hrs), an inverted phase contrast
microscope (IX-70, 20X or 40X objective, Olympus) and a high resolution CCD video
camera (CCD-72, Dage-MTI, Inc.) were used to visualize cell adhesion.
To determine whether the modified peptide had bi-functional capabilities, the
peptide was interacted with PPyCl samples, then subsequently with neuronal PC 12 cells.
The T59-GRGDS peptide will confirm its bi-functional capabilities if there is
monodisperse cellular attachment to PPyCl. Images were taken to evaluate these
experimental results and are represented in Figure 5.3 and 5.4.
57
Figure 5.3: PC12 cells interacted with PPyCI. 5.3A) T59-GRGDS interacted with PPyCl
and PC12 cells. 5.3B) No peptide interacted with PPyCl with PC12 cells. 5.3C) T59-
GRGDS peptide interacted with PPyCI and PC12 cells in serum containing media.
5.3D) No peptide interacted and no PC12 cells. All samples interacted in serum free
media unless otherwise noted. Bar =50 pm.
As can be seen from the above optical micrographs, when T59-GRGDS was
interacted with PPyCl and PC12 cells in serum-free media (Figure 5.3A) the cells are
distributed evenly across the surface of the sample. But when no peptide was present to
attach the cells to PPyCl (Figure 5.3B), the cells create cellular clumps or aggregates.
This phenomenon typically represents nonspecific attachment to the surface. Additionally
experiments were performed to determine if T59-GRGDS binds sufficiently to PC12
cells to deter cellular clumping in serum containing media. As seen previously from
Figure 5.2, there should be approximately 1.32x1015 peptides/mm 2 to promote adhesion.
The micrograph representing this data shows clumpy cells, Figure 5.3C. This data
58
suggests that, although T59-GRGDS has the ability to bind PPyC1 and PC12 cells in
serum-free media, there are most likely protein interactions that are much stronger in
serum-containing media which prevent the interaction of the GRGDS portion of the
modified peptide with the PC 12 cellular surface.
To analyze the binding of PC12 cells to PPyCl more thoroughly, rotational
agitation was used. If the above figures (Figure 5.3A-C) are compared in actual numbers
of cells on the surface of PPyCl, then it is obvious that the serum containing interaction
binds more PC12 cells to PPyCl. It is assumed that the serum containing media binds the
cells to PPy(:C non-specifically and the binding of the cells to PPyCl through T59-
GRGDS is a specific recognition event. To test this hypothesis the same conditions were
used for peptide adhesion to PPyCl and either serum-free or serum containing media was
used to interact PC12 cells with the functionalized PPyCl except after the cellular
interaction 5 min of medium rotational agitation was used to disrupt the PC12 cells
tethering to PPyCl.
Figure 5.4: 5.4A) PPyCI/T59-GRGDS/PC12 cells in serum free media, 5.4B)
PPyCI/T59-GRGDS/PC12 cells in serum free media after 5 min agitation, 5.4C)
PPyCI/PCI2 cells in serum containing media, 5.4D) PPyCI/PCI2 cells in serum
containing media after 5 min agitation.
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The optical micrographs comparing the specific tethering of PC12 cells to PPyCl
through the T59-GRGDS peptide (Figure 5.4A) and the non-specific attachment of the
cells to PPyCl by serum proteins (Figure 5.4C) before and after 5 min of rotational
agitation show that the non-specific attachment can be physically disrupted (Figure 5.4D)
while there are no significant lose of cells on the T59-GRGDS tethering, as shown in
Figure 5.4B.
Neurite extension was also studied by inducing differentiation of PC12 cells.
After the cells were seeded, as described previously, soluble 100 ng/ml -Nerve growth
factor (Invitrogen) was incorporated in serum-free media for 7 days and imaged using an
inverted phase contrast microscope.
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Figure 5.5: T59-GRGDS promotes PC12 cell adhesion in serum-free environment.
5.5A) PPyCI sample without T59-GRGDS or PC12 cells interacted, 5.5B) with 15 pM of
T59-GRGDS peptide interacted prior to cellular incubation, 5.4C.) Extension of neuronal
processes was induced with 100 ng/ml 13-NGF for 7 days in serum-free media.
Scale bar = 50 and 5 pm.
As was shown in Figure 5.3B, samples without T59-GRGDS did not permit cellular
adhesion, whereas the sample with T59-GRGDS did support cell adhesion with
monodisperse cells (Figure 5.5B). In addition to cell adhesion, the PPyCl-T59-GRGDS
modified surface also supported neurite outgrowth (Figure 5.5C). This represents a
significant step forward in the possible use of this system for in vivo cell studies.
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5.3 Conclusions
After selection of T59 from the peptide-phage library, the peptide was modified
with a cellular binding domain of GRGDS. This hepta-peptide binds to the integrin
binding domain, which is present on most cells. This modification to the C-terminus of
the T59 peptide facilitates a bi-functionality that can bind both the PPyCl surface and the
cellular surface. Initial studies were performed to optimize the input concentration of
peptide. This value was determined to be 15 M for a PPyCl sample size of 0.5 cm2.
Additionally, studies were performed to confirm the presence of bound T59-GRGDS in
both serum and serum-free media after periods of up to 1 month. This data resulted in the
presence of 74.0% and 79.8% of original surface concentration of peptide bound. These
experiments were essential in determining the quantity of peptide available for
bi-functional adhesion to PC12 cells. From the bi-functional binding experiments, it is
seen that the modified peptide does mediate cellular attachment of the PC12 cells to the
surface of PPyCl. To determine if the PC12 cells attached to PPyCl non-specifically by
serum proteins were more adherent than T59-GRGDS tethered cells, rotational agitation
created a physical disruption with the serum containing attached cells significantly
reducing the cells on the surface of PPyCl. While the T59-GRGDS tethered cells quantity
remained unchanged. Additionally, not only does the bi-functional peptide promote
cellular attachment to PPyC1, it also provides a substrate where neurite extension can
occur through the differentiation of the PC 12 cells with P3-NGF.
These above results provide a proof of concept that the use of T59-GRGDS as a
bi-functional linker is a viable option for the use in a nerve guidance channel. By being
able to specifically link nerve cells and the nerve guidance channel substrate one is able
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to control the cellular attachment within the conduit, which has been one of the major
limitations thus far in nerve guidance channel device fabrication. This modified peptide
would provide a proportional increase in regeneration capabilities when coupled with
electrical stimulation of the conduit.
Chapter 6: Yeast Surface Display of ScFv against Chlorine-Doped Polypyrrole
6.1 Purpose
Single-chain antibody fragments (scFv), as opposed to full length antibodies, are
used to decrease immunogenic response within the body. Numerous studies have been
performed using yeast surface display of scFv to screen biological relevant targets, such
as T-cell receptors and epidermal growth factor fragments [49-51]. Alternatively, the
Belcher lab has performed many phage based selections against semiconductors and
metals [35-38, 40, 52]. Learning from these screening studies, it seems that the antigen
binding tool created by biological selection of materials is a superior technique compared
to that of direct surface chemical modification. Unfortunately, there is also a size
dilemma of using phage to screen materials. Phage with a length scale of 6 nm x 880 nm
require secondary markers to visualize optically. Yeast as an alternative are easily
visualized optically with their 4-5 jgm size and a doubling time that is comparable to
phage in the selection process. Another advantage of using antibodies is there high
specificity for biological antigens [53]. In this work the biological antigen would be
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replaced with non-biological PPyCl, with the hope of obtaining the same high affinity
binding to the surface. The use of the scFv's provides an order of magnitude advantage of
overall binding compared to peptides used for the same purpose [54]. To utilize all of the
yeast display system's advantages and the continued staple of biological selection of
inanimate materials, this study focuses on yeast display selection of a single human
derived scFv that binds to a tissue engineering applicable polymer, PPyCl.
6.2 Experimental Methods
A human derived scFv antibody library extra-cellularly linked to Saccharomyces
cerevisiae, described previously by Boder and Wittrup [35-38, 40, 52, 55, 56], consisting
of lx108 different clones was used to screen PPyCl. Screening consisted of inducing
2x 109 clones for 48 hrs in select-galactose containing media supplement with 100 gg/ml
Pennicillin/Streptomyocin (SG-CAA P/S) and interacting these clones with a
pre-sterilized 0.5 cm2 sample of PPyCl in SG-CAA P/S for 24 hrs. The resultant
interaction was rinsed twice with blocking buffer (0.1 M TBS, 5 mg/ml BSA,
100 tg/ml P/S). A wash step proceeded in SG-CAA for 2 hrs at 25°C. The PPyCl sample
was removed from the wash solution and transferred to a new tube to enrich the
population of bound clones in select-dextrose containing media (SD-CAA) incubating
overnight at 300C. This screening continued for five rounds under the same conditions
with 62 sample clones acquired from rounds three through five. A thorough diagram of
the yeast selection process is represented in Figure 6.1.
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Figure 6.1: Illustration of the process for selection of antibodies that recognize the
surface of PPyCI.
Isolation and sequencing of these clones consisted of selecting a single yeast
colony with a sterile pipette tip from a select-dextrose plate grown for 48 hrs at 300 C and
growing this colony overnight in SD-CAA supplemented with P/S at 300C, yeast plasmid
isolation using RPM® Yeast Plasmid Isolation Kit (Q-Biogene), transformation of the
clone's DNA into Top 10 One Shot® Electrocompetent Cells (Invitrogen). The
corresponding bacterial clone's DNA were isolated using QIAprep Spin Miniprep Kit
(Qiagen). The DNA was prepared with a forward and a backward primer, for sequence
conformation,, and sequenced at MIT Biopolymers Lab. Acquired sequences were
compiled and analyzed using SequencherTM (Gene Codes Corp.) and NIH IgBlast was
used to determine sequence homology, Appendix 1 [57].
From the selection process nine unique clones were identified. These clones were
induced from individual yeast colonies in SG-CAA supplemented with P/S. The cultures
were grown until approximately 0.25 OD600nm/ml (approx. 2.5x106 yeast/ml). Yeast were
interacted with the substrate for 18 hrs at 250C with medium rocking in SD-CAA or SG-
CAA 5 mg/ml BSA and P/S in triplicate. The samples were then rinsed twice with SD-
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CAA or SG-CAA 5 mg/ml BSA P/S containing 0.1% (v/v) Tween-20. The samples were
then washed for 2.5 hrs with the same solution. The wash solution was then removed and
replaced with fresh SD-CAA 5 mg/ml BSA and P/S. The samples were imaged
immediately and subsequently enriched for 43 hrs with optical density (OD600nm/ml)
readings taken immediately. Images and OD readings are represented in Figure 6.3 and
6.4, respectively.
6.2 Results
After 5 rounds of screening, clone sequences were compiled and are represented
in Figure 6.2.
The 9 clones named Y1 -Y9 were tested for binding affinity to PPyC1 by
interacting -2x 106 cells with the surface in both galactose and dextrose containing media
(galactose induces the expression of the cellular surface antibody) as described in the
Experimental Methods. Images were taken after clone interaction with PPyCl samples
and washing, but before growth, Figure 6.3.
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Y1 (x16)
QVQLVQSGAE VKKPGASVKVSCKASGUTFTSYGSWVRQAPGQGLEWIGWIYNGNTNYAK
IQGRVTITTDISTITAYMELRILRSDDTAVYICARDSHPMGIPFDHWGQGTLVTVSSGILGSGGG
GSGGGGSGGGGLQEF*
Y2 (x 15)
QVQLQQSGPC;LVKPSQTLSLTCAISGDSVSSNSAAWNWIRQSPSRGLEWLGRTIYRSKWYNDYA
VSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCARVGCGTYCNNWFSWGQGTLVTVSSGSAS
APTGILRSGGGGSGGGGSGGGGSDIQITQSPSSLSASVGDRVTITCRASQSISIYLNWYQQKUGKA
PKILIYIASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYICQQGDSTPYTFGQGTKLEIKSGILE
QKLISEEDL*
Y3 (x2)
QVQLQQSGPGLVIPSQTLSLTCAISGDIVSSNSAAWNWIRQSPSRGLEWLGRTYIRSKWYNYA
SVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCARRTGTGIDYWGQGTLVTVSSGILGSGGGGSG
GGGSGGGGLQEF*
Y4 (x2)
QGTAAAVRSRPGEALADPLTHLC HLRGQCLYQQCCLELDQAVPIERP*
Y5 (xl)
IVQLVESIGGLVKPGGSLRLSCAASGFTFSNIVMSWVRQAPGKGLEWVGRISKpGTTDYA
AVKGRFTIIRDDSKNTLYLQMELNSEDTAIYECTTVPLYRTG WDFDFWGPGTLVTVSSGILGS
GGGGSGGGGSGGGGSNFMLTQPHSVSESPGKTVTISCTRSSGSIAJVQWYQQRPGSSPTTVIYE
INQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNPYVFGGGPRSPPIRNSRTKTY
F*
Y6 (xl)
QVQLVQSGAE VKKPGASVKVSCKASGITFTSYGISWVRQAPGQGLEWIGWIYNGNTNYAiK
QGRVTITTDISTITAYMEIR RSDDTAVYICARDSHPMGIPFDHWGQGTLVTVSSGILGSGGG
GSGGGGSGGGGLQEF*
Y7 (x2)
QVQLQQWGAGLLKPSETLSLTCAVYGGSFIYYWWIRQPPGKGLEWIGEI{SGSTNYNPSLKSR
VTISVDTSKNQFSLKLSSVTIADTAVYYCARDLTSSWFGFDYWGHGTLVTVSSASTKGPSGILGSG
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GGGSGGGGSGGGGFETTLTQSPAFMSATPGDIVISCKASQDIDDDMNWYQQKPGEAAIFIIQEAT
TLVPGIPPRFSGSGYGTDFTLTINNIEEDAAYYFCLQHDNFPLTFGQGTKVEINPEF*
Y8 (x22)
QVQLVQSt4EVIKPGSSVKVSCKAIGITFSIYAISWVRQAPGQGLEWMGGIPI I 1UYAQKFR
GRVTITADISTITAYMELSSLRSEDTAVYYCARVGGGYNGRQGYYYYAMDVWGQGTTVTVSSGI
LGSGGGGSGGGGSGGGGSEITLTQSPAFMSATPGDKVIISCKASQD-DDMNWYQQKPGIAIF
IIQEATTLVPGIIPRFIGSGYGTDFTLTINNIESEDAAIYFCLQHIFPLTFGQGTKVEI KSGILEQKLI
SEEDL*
Y9 (xl)
QVQLWSLGEAWYSLGGP*
Figure 6.2: Amino acid sequences of scFv-yeast clones selected from rounds 3-5 yielded
9 different sequences. The occurrence of these clones is as follows: Y l:16, Y2:15, Y3:2,
Y4:2, Y5:l, Y6:l, Y7:2, Y8:22, Y9:I. Unhighlighted regions are antibody framework
and/or linkers. Yellow regions are CDRs of the antibody. Green amino acids are
deviations from the best matching antibody from an NIH IgBlast. (Appendix 1)
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Figure 6.3: Optical micrographs of human derived scFv clones tethered to yeast and
bound to the PPyCI substrate. 6.3A-I) Y1-Y9. 6.3J) PPyCI. Scale bar = 10 m.
The micrographs from Figure 6.3 were taken on an Olympus IX51 inverted
optical microscope equipped with an Olympus Qcolor digital CCD with images collected
using SimplePCI version 5.2.0.2404 (Compix Inc.) and represent the SG-CAA interacted
clones. As seen in the figure above yeast clones Y1, Y3, Y5-Y9 bind to PPyCl, but not
nearly to the extent of clones Y2 and Y4. Figure 6.4A is the graphical representation of
the growth after a period of 43 hrs of the clones interacted in SG-CAA media with
PPyC1. Figure 6.4B represents the galactose to dextrose binding ratio of the clones when
interacted in either media SG-CAA or SD-CAA, all clones were interacted in triplicate.
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6.4A Yeast Growth at 43hrs
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Figure 6.4: 6.4A) The yeast clones YI-Y9 with OD 600nm/ml readings after 43 hrs of
growth off of PPyCI. Highlighted by diagonal hatchings are significant binding clones Y2
and Y4, 6.4B.) Yeast clones Y1-Y9, with a significant G/D ratio from Y2. Error bars =
±+ SD.
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From Figure 6.4A it is apparent after 43hrs of growth that the most abundant
yeast samples are Y2 and Y4. Assuming that all clones enrich at the same rate, Y2 and
Y4 clones had to have had initially more binding yeast on the surface of the PPyCl
sample after washing and before enrichment began. Therefore of the nine yeast clones
selected for PPyC1, Y2 and Y4 are the best binders in SG-CAA media.
The galactose/dextrose ratio of the yeast samples interacted with PPyC1, in Figure
6.4B, provides a better insight into what the binding of these clones is to PPyCl. As one
can see the G/D ratio of Y4 is significantly lower than that of Y2, which may mean that
cell wall proteins other than scFv are binding to the surface of PPyCl. The Y2 clone G/D
ratio on the other hand is significantly larger than that of Y4. Because the ratio is much
greater in favor of galactose containing media than dextrose containing media, one can
deduce that the scFv of Y2 is responsible for the binding of the Y2 clone to the surface of
PPyCl. Therefore, of the nine yeast clones selected for PPyCl Y2 and Y4 clones are the
best binding, but Y2 possesses the best ability to turn on and off binding of the yeast
clone to the surface of PPyCl.
After binding studies were performed the difference between Y2 and Y4 sequence
composition came to our attention. Referring to Figure 6.1, the Y2 clone is comprised of
a full scFv with minor amino acid substitutions in the CDR2 and CDR4 regions along
with additional substitutions in the VL region of the scFv. This clone is closest in
homology to VH6-1 (NIH Ig: AB019441), and 02 (NIH Ig: X59312) [57]. The Y4 clone
is the result of a frame shift, and therefore no specific homology can be found. Initially, it
was surprising that both types of clones, a full scFv and frame shift, could bind to PPyC1,
but after individual binding studies were performed the full scFv (Y2) was evidently the
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better binding of the two. This was determined by the G/D ratio of binding to PPyCl, thus
revealing that Y4 is more likely a non-specific interaction because of its ability to bind to
PPyCl in dextrose containing media. Additionally, the use of full-length scFv in Y2
would provide better water solubility for labeling and possible biomolecule conjugation
to the PPyCl surface.
6.3 Conclusions
Screening human derived scFv through yeast surface display is an effective
method for determining recognition events on PPyCl. These recognition events would not
normally occur in nature, but through molecular interaction of scFv and polymeric
materials scientist are able to control their interaction. The complete scFv Y2 was
statistically the best binding clone out of nine different clones selected from 62
sequences. The next best binding clone was Y4, which is a frame shifted scFv, that is
comparable in binding to Y2 in galactose containing media, but the ability to control the
binding of the Y4 clone is insufficient in dextrose containing media implying that yeast
cellular surface proteins other than that of Y4 are responsible for binding the PPyCl
surface.
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Chapter 7: Antibody Mediated Recognition of Chlorine-Doped Polypyrrole
7.1 Purpose
To make this technology applicable further down the biomedical device pipeline
it is necessary to implement cellular recognition of the biomedical applicable polymer
mediated by the antibody that specifically recognizes that polymer. From Chapter 6, yeast
surface display of scFv antibodies has been shown to effectively find a specific
recognition antibody to the surface of PPyCl. The Y2 antibody derived from this
screening can possibly be used to integrate into cell types and mediate binding of these
cells to PPyC1, where normally they would not. This integration, if successful, would
show a proof of principle that the Y2 antibody could be used as a mediator for attachment
of potential therapeutic cell lines within a nerve guidance channel system.
The vehicle needed for this integration needs to able to display the Y2 antibody
on the exterior of mammalian cells. A fine candidate for this approach is that of the
pDisplayTM vector (Invitrogen). pDisplayTM is a mammalian expression vector designed
to tether recombinant proteins to the surface of mammalian cells. The antibody of interest
is anchored to the cell surface by cloning the gene of interest in frame with the vectors
unique N-terminal secretion signal and the C-terminal transmembrane anchoring domain
of platelet-derived growth factor receptor (PDGFR). In contrast to phage display vectors
which operate exclusively in prokaryotic cells, the pDisplayTM vector offers the
advantage of having the displayed antibody processed in mammalian cells. Therefore,
recombinant antibodies of eukaryotic origin, such as the scFv from humans, that are
expressed from pDisplayTM more closely resemble their native form. In addition to the
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N-terminal cell surface targeting signal and C-terminal transmembrane anchoring
domain, the pDisplayTM vector contains the following key features: T7 promoter/priming
site for sequencing of inserts, recombinant proteins expressed contain the hemagglutinin
A and myc epitopes for detection by immunolabeling, neomycin resistance for selection
in mammalian cells using Geneticin®, and an ampicillin resistant gene for selection in
E. coli. Previous work has been conducted using a form of pDisplay to express c-jun on
SK-BR-3 human breast carcinoma cells for the ultimate binding of these cells to phOx
hapten [58]. Thus, this previous work proves that this technique is a useful tool for the
display of recombinant proteins on the surface of mammalian cells. From the
experimentation that is to be conducted it is within these same constraints, except for the
fact that the antibody to be displayed on the surface of the mammalian PC 12 cell will be
binding to a therapeutically interesting polymer, PPyCl.
7.2 Experimental Methods and Results
For the implementation of using the Y2 antibody to mediate cellular recognition of
PPyCl there are three stages of experimentation that were performed. The first stage
consists of integrating the Y2 antibody coding region of DNA into the pDisplay plasmid
that will be used for integration into PC12 cells. This stage uses standard molecular
biological techniques such as polymerase chain reaction (PCR), enzyme digests, and
ligation of both the Y2 insert with the vector pDisplay. Additional work complementing
this stage was the use of spectrophotometric quantitation of DNA and sequencing to
confirm the presence of the Y2 insert in frame with the vector pDisplay forming an
Y2-pDisplay plasmid. The second stage after creating the Y2-pDisplay plasmid was the
use of it into PC12 cells mediated by a lipid transfection technique. This stage of the
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work required characterization of the Y2 antibody being expressed on the surface of
PC 12 cells which was done by immunological labeling of the hemagglutinin A portion of
the Y2 antibody that is expressed extra-cellularly. The techniques used to analyze this
stage of the work were fluorescence microscopy and flow cytometry. The third and final
stage of this experimentation consisted of evaluating the binding capability of the Y2
expressing PC12 cell to the surface of PPyCl which is performed by interacting
Y2-pDisplay transfected PC12 cells with a sample of PPyCl and evaluating the degree of
binding by imaging using optical microscopy.
The initial construction of the plasmid that will represent the Y2 antibody that
recognizes the surface of PPyCl starts with the yeast surface display plasmid DNA. This
DNA is extracted with the RPM® Yeast Plasmid Isolation Kit (Qbiogene) and transfected
into One Shot® Topl0 E. coli (Invitrogen) for an increase in DNA concentration. A
BioRadTM Micropulser was used to electroporate the yeast DNA into the bacterial cells,
which was set to Ec2 with a time constant of 5.90 ms and an average voltage passed of
4.0 kV using a 2 cm electroporation cuvette (VWR). The electroprated bacteria were
incubated for 1.5 hrs to allow recovery at 370C and plated using spreading beads on LB
plates supplemented with 100 jig/ml ampicillin and incubated overnight at 37°C. The
resulting bacterial colonies were amplified in LB media supplemented with 100 gg/ml
ampicillin overnight and spun down with the bacterial pellet collected for DNA
extraction using QIAprep Spin Miniprep Kit (Qiagen). The resulting bacterial DNA was
quantitated spectrophotometrically and confirmed by sequencing and used for subsequent
plasmid construct experiments.
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The portion of the bacterial DNA that codes for the Y2-antibody was isolated by
using a forward and reverse primers with incorporated recognition sites for the restriction
endonucleases Bgl II and Sal I, respectively labeled pD5'BglII and pD3'SalI in
conjunction with the Expand High Fidelity PCR System (Roche). The PCR parameters
deviated from the protocol because of the size of the Y2 insert and are represented in
Table 7.1. A schematic of Y2 DNA used in PCR, double restriction endonuclease digest,
and the ligation is represented in Figure.7. 1.
Table 7.1: PCR
sticky ends.
Temp (C) Time (s) Cycle
Initial Denature 94 120 lx
Denature 94 35 20x
Anneal 60 30 20x
Elongate 72 60 20x
Final Elongation 72 420 lx
Cool 4 600 lx
parameters for the production of the Y2-insert with 5'BglIl and 3'Sall
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The PCR product was run on a 1% TAE agarose gel set to a constant voltage of 125 V
with standard controls of a 1 kilobase ladder (NEB), 5' and 3' primers, and neat Y2
E. coli DNA. The gel was rinsed after staining with ethidium bromide and imaged using a
BioradTM Gel Doc system as can be seen in Figure 7.2.
Figure 7.2: Fluorescent image of the PCR product from the use of a 5' and 3' primer to
the Y2 E. coli plasmid creating an 902 bps Y2-antibody insert.
The resulting bands associated with the 902 bps PCR product which will express the Y2
antibody were extracted from the gel and purified using the QIAquick Gel Extraction Kit
(Qiagen). The DNA was then quantitated spectrophotometrically to prepare for the
double restriction endonuclease digest.
The double restriction endonuclease digest for both pDisplay and the Y2 PCR product
called Bgl II-Y2-Sal I consisted of selecting a buffer that both enzymes, Bgl II and Sal I
can function properly in, bovine serum albumin incorporation at a concentration of
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100 mg/ml to stabilize the oligonucleotide components and obviously Bgl II and Sal I
enzymes with both the vector pDisplay and insert Y2. The vector is super-coiled and was
boiled at 100°C for 5 min to uncoil prior to the digest. The digest proceeded at 370C for 1
hr and was run on a 1% TAE agarose gel set at a constant voltage of 125 V. Negative
controls run on the gel consisted of enzymes with no insert or vector DNA and super-
coiled pDisplay which can be seen in Figure 7.3.
Figure 7.3: luorescent image ot double restriction endonuclease digest tor both Y2 and
pDisplay.
As can be seen in Figure 7.3 there is a consistent separation of expected products of
Y2-DD around 822 bps, pDisplay-DD around 5299 bps, no enzymes, and because the
super-coiled pDisplay has a greater electrophoretic mobility, due to its reduced size
compared to pDisplay-DD, it is lower on the gel. The Y2-DD and pDisplay-DD band
were collected as before and their respective oligomers were extracted and quantitated as
previously described.
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Ligation of the Y2 insert into the linearized vector pDisplay creating the Y2-
pDisplay plasmid was initially performed with T4 DNA ligase (NEB) and traditional
ligase reaction buffer (50 mM Tris-HCl,10 mM MgCl 2, 1 mM ATP, 10 mM dithiothreitol,
25 pg/ml BSA, pH 7.5 at 25°C) with no transfection of the plasmid into One Shot® TOP
10 E. coli. Because no transfection occurred an alternative ligase buffer, Quick Ligation
Reaction Buffer (NEB), was used which decreased the time while increasing the
efficiency of the ligation. This was evident by the transformation of 0, 3, 6, and 12 molar
excess of insert to vector reaction mixtures ligated for 5 min at 250 C into electrically
competent One Shot® ToplO E. coli (Invitrogen). The transfection was performed as
previously described for electrically competent One Shot® Top 1O E. coli. Transformation
efficiencies were determined for a positive control, pUC19, and the 4 ligation reactions
by counting the number viable bacterial colonies forming units (cfu) grown overnight at
37C on LB plates supplemented with 100 gg/ml Ampicillin. The quantities were as
follows: pUC19 = 204 cfu, Ox 1 cfu, 3x = 2 cfu, 6x = 67 cfu, 12x = 252 cfu. The
equation for the calculation of transformation efficiencies is represented in Equation 7.1
and the values in Table 7.2.
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Equation 7.1: Transformation efficiency
transformation efficiency number of colonies (cfu) 1x103 (ng) total ligation volume (l)
(cfu/gg) weight of DNA (ng) 1 (pg) plated volume (l)
Sample ID cfu weight of total Rx plated transformation
DNA (ng) volume (l) volume (pl) efficiency (cfu/gg DNA)
pUC19 204 0.01 302 10 6.16E+08
Ox 1 5 302 100 6.04E+02
3x 2 5 302 100 1.21E+03
6x 67 5 302 100 4.05E+04
12x 252 5 302 100 1.52E+05
Table 7.2: Transformation efficiencies for the ligation reactions with a positive control of
the plasmid pUC 19.
The transformation efficiency for the positive control of pUC19 is as expected around
lx109 cfu/gLg DNA and it is apparent as there is an increase in transformation efficiency
as the insert to vector ratio increases. This increase is observed by the span of the
transformation efficiency by four orders of magnitude from 102 to 105. This is not
necessarily essential to the process, but did show that, at least using pDisplay and the
specified length of the Y2 insert, as the ratio of insert to vector is increased there is an
increase in transformation efficiency. Colonies from these plates were collected and
grown in LB media supplemented with 100 jig/ml ampicillin overnight at 370 C to collect
the bacterial DNA, as previously described using the QIAprep Spin Miniprep Kit, for
subsequent sequence confirmation of the Y2-pDisplay plasmid, quantitation, and
transfection into PC 12 cells. Sequencing of the grown colonies confirmed the presence of
the Y2 insert in frame with the pDisplay vector as can be seen in Figure 7.4.
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N42576 25 MIL BELF09_035 2
N42576 27 M'L BEL H09 033 2
N42576 20 MiL BEL A09 040 2
42576 28 MiL BEL A1 1043 2
N42576 1 MIL BEL H07 025 2
N42576_18 MIL BEL C07 026 2
N42576 2 MIL BEL E09 036 2
N42576 21 MIL BEL BC9 039 2
N42575 22 -Ml -EL C09 038 2
N42576 26 Ml_ BEL 09 034 2
N42576 12 MIL ABEL?07 032 2
N42576 06 MIL BEL C05 022 2
N42576 13 MIL EL 07 031 2
N42576 1 lMIL EL 1105 C17 2
N42576 1 MIL BEL C05 018_2
N42576 15 MIL GEL D07 029 2
N42576 07 MIL BEL D05 021 2
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Figure 7.4: Y2-pDisplay sequences confirming Y2 insertion into pDisplay (Sequencher)
After the construction of the Y2-pDisplay plasmid the second phase of the
experimentation commenced by transfecting the plasmid into PC12 cells. This was
performed by using Lipofectamine 2000TM (Invitrogen) as the transfection vehicle.
Specifically, the PC12 cells were plated in 0.5 ml of standard growth media without
antibiotics onto collagen coated tissue culture polystyrene at 2.5 x 105 cells per well to
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achieve 90% confluency the day of transfection. 2 gl of Lipofectamine 2000TM reagent
was diluted with OPTI-mem I Reduced Serum Medium (Invitrogen) and incubate for 5
min at 250C. The Lipofectamine 2000TM dilution reagent was combined with a 50 Rtl
dilution of the Y2-pDisplay DNA at a quantity of 0.8 gg in the same medium and
DNA-Lipofectamine complexes were allowed to form for 20 min at 250C. The complexes
were then introduced into the PC12 wells for transfection for a period of 4 hrs at 370 C
and 5% CO2. After 4 hrs the cellular media was replaced with fresh media. The cells were
then incubated for 24 hrs to allow the progression of the transfection to take place. After
this period of time the cells were sub-cultured into flasks containing complete media
supplemented with 200 gg/ml of Geneticin® to allow for specific growth of only
sufficiently transfected cells. After a period of 1 week cells were collected from these
cultures and were used to determine the presence of antibody expression on the surface of
the PC12 cells, quantitate the number of antibodies on the surface of the PC 12 cells, and
test binding of the Y2-pDisplay transfected cell (Y2-cell) line to the surface of PPyCl.
Conveniently, the Y2-pDisplay cell line can be fluorescently labeled for analysis
using both fluorescent microscopy and flow cytometry. The labeling was performed by
removing the non-adherent cells from the collagen coated flasks using X trypsin-EDTA
at approximate concentration of 105 cells per flask and centrifuging them for 30 sec at
3000 rpm. The cells were then washed twice with 700 ,ul of PBS supplemented with
1% (w/v) BSA. The primary antibody, anti-hemagglutinin A (clone 12CA5) (Roche), was
then introduced at a volume of 100 gl and dilution of 1/1000 in PBS/l%BSA and
incubated on ice for 30 min. The cell suspension was then washed twice with 700 Rl of
PBS/1%BSA and centrifuged to remove unbound primary antibody. The cells were then
83
resuspended in 100 gI of secondary antibody, goat-anti-mouse-FITC (Invitrogen), at a
dilution of 1/1000 in PBS/1%BSA and were incubated on ice for 30 min. The cells were
again washed twice with 700 l of PBS1%BSA with centrifugation of the cells in
between washes for 30 sec at 3000 rpm. The fluorescently labeled cells were then
resuspended in 250 gl PBS/l%BSA. The controls for these experiments were
untransfected PC12 cells unlabeled, interacted with primary and secondary antibodies,
interacted with only secondary antibody, Y2-cells unlabeled, and interacted only with
secondary antibody.
The confirmation of the presence of the Y2 fusion to the cellular membrane of the
PC 12 cell was initially confirmed by immunolabeling the hemagglutenin A portion of the
protein. Fluorescent images of this experiment can be seen in Figure 7.5.
84
85
Figure 7.5: Bright field (bf) and fluorescent (fl) optical micrographs of immunolabeled
PC12 and Y2-cells. 7.5A) PC12bf, 7.5B) PC12fl, 7.5C) PC12-2°bf, 7.5D) PC12-2°fl,
7.5E) PC12-1°-2°bf, 7.5F) PC12-1°-2°fl, 7.5G) Y2bf, 7.5H) Y2fl, 7.51) Y2-20 bf, 7.5J)
Y2-2°fl., 7.5K) Y2-1°-2°bf, 7.5L) Y2-1°-2°fl. 1° = primary antibody, 2 = secondary
antibody, Scale bar = 20 jgm.
As expected from the immunolabeling of the PC12 cells one is able to observe that
there is little to no background fluorescence from PC 12 cells TheY2-cells with no label
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have little to no fluorescent signal and one is also able to observe that the secondary
antibody does not non-specifically label the Y2-cells. The Y2-cells incubated with
primary and secondary antibodies display a much larger fluorescent intensity than that of
all the other control samples. Thus immunlogically confirming the presence of Y2
antibody being displayed on the surface of the PC 12 cells.
The immunological labeling of the Y2 antibody fused to the cell membrane of the
PC12 cell also lends itself to characterization by flow cytometry. What one hopes to
obtain from this technique is the quantity, within an order of magnitude, of how many
antibodies are being displayed on the surface of the cell. This quantity can initially be
compared to that the expression level on the surface of S. cerevisiae, which is around
50,000 copies per cell [54] and eventually be used for cell seeding densities when
modified cell lines are incorporated into the nerve guidance channel for in vivo
applications. Immunolabeling was performed as described previously with the same
controls. The quantity of antibodies on the surface of cells were back calculated from
quantification with the QuantumTM MESF high level kit (Bangs Laboratories) and
analyzed by QuickCal® version 2.3 (Bangs Laboratories). A Coulter Epic XL cytometer
was used to analyze the cells with flow plots represented in Figure 7.6 and analysis of
these plots in Figure 7.7.
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Figure 7.6: Flow plots of immunolabeled PC12 cells. 7.6A) Quantum MESF kit
calibration, 7.6B) untransfected unlabeled cells, 7.6C) untransfected 2, 7.6D)
untransfected 1°2° , 7.6E) Y2-cells unlabeled, 7.6F) Y2-cells 20, 7.6G) Y2-cells 1°2°.
When the flow plots are looked at as a whole, it is observed that there is a slight
forward to side scatter difference between untransfected (7.6B-D) and Y2-cells (7.6E-G).
This slight difference in scatter is most likely caused by the Y2 antibody being expressed
on the surface of cell. What really stands out from this data is the two populations of the
cells in 7.6G representing unlabeled and labeled cells as the log scale increases. This is
important because one is able to analyze unlabeled and labeled Y2-cells with the
calibration to determine the degree of labeling and thus an order of magnitude
representation of Y2 antibodies on the surface of PC 12 cells.
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Figure 7.7: QuickCal® analysis of flow plots determining the degree of fluorescence
from the plots.
If it is assumed that there is one secondary label per primary antibody and one
primary antibody per Y2 antibody, then the molecular equivalent of soluble fluorophore
(MESF) of the Y2-cells labeled with the primary and secondary antibody (y2-12) can be
used to determine the relative quantity of the Y2 antibody on the surface of the PC 12 cell.
Other values needed for this calculation are protein concentration of the secondary
antibody and the fluorophore quantity per protein molecule in the secondary antibody.
These values were determined by diluting the secondary antibody 50 times in
PBS/1%BSA and taking the absorbance at 280.0 nm, for amino acids, and 494.0 nm,
fluorophore, and were as follows: 280.0 nm = 0.0709 au, 494.0 = 0.1345 au. The above
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values were calculated according to Equation 7.2.
Equation 7.2:
A) Protein Concentration
B) Fluorophore/Protein Molecule
(Abs280nm - (Abs494nm x 0.30)) x dilution
A) protein concentration (M) =
203,000 cm-' M-1
Abs494nm x dilution
B) fluorophore/protein molecule =
68,000 cm-' M-1 x protein concentratiom (M)
From Equation 7.2A the 0.30 factor is from the absorbance of the protein at 494.0
nm and the molar absorbtivity is a typical value for this FITC conjugated secondary
antibody and from Equation 7.2B the molar absorbtivity is a typical value for the FITC
portion of the antibody. Using the equations from above and the absorbance values at
280.0 nm and 494.0 nm the protein concentration and fluorophore per protein molecule
were calculated with the results being: protein concentration = 7.524 ,gM and
approximately 13 fluorophore molecules per protein molecule. Thus when you take the
MESF of the y2-12 cells (40,471) and divide it by the 13 fluorophore molecules per
protein molecule and again take into account the assumptions of a single secondary
antibody per primary antibody and a single primary antibody per Y2 antibody on the
surface of the cell we arrive at a value of approximately 3,100 Y2 antibodies on the
surface of the PC12 cell. As previously described the yeast cells that express the Y2
antibody on its surface have approximately 50,000 copies of the antibody. When these
two values are compared there is only a single order of magnitude difference in the
expression of the antibody on the surface of these cells, which without expression
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optimization, is a sufficient amount to acknowledge a success of creating a neuronal cell
line that could bind to PPyCl. Previous values given for the expression level of antibodies
on the surface of mammalian cells range from approximately 100 to 5,000 depending on
the method of quantization used [58, 59].
The final stage of incorporating an antibody displaying plasmid into a mammalian
cell was used to test the hypothesis that one can utilize a non-biological binding entity
across species with retention of binding capabilities. This was tested by using the
Y2-cells and a sample of PPyCl allowing them to interact with one another and ultimately
evaluate binding. The 0.5 cm2 PPyCl samples were pre-sterilized with ethanol as before.
The Y2-cells were collected from culture flasks and centrifuged for 30 sec at 3,000 rpm
to pellet the cells. They were washed twice with PBS/l%BSA prior to interaction with
the PPyCl sample. The interaction ensued for 1 hr in 500 gl PBS/l%BSA at 250C with
medium rocking with a cell density of lx105 cells/mi. The samples were then washed
twice for 5 min with medium rocking to remove any unbound cells from the surface of
PPyCl. 500 jll of PBS/l%BSA was finally added to image the cells in media therefore
not imaging stagnant cells. To test the binding capability of ordinary cells, untransfected
PC 12 cells were used. To determine the specificity of the Y2 antibody on the PC 12 cells
surface an alternative expressing clone was used. This clone was derived from a cadmium
sulfide specific antibody and selected in the same manner, through yeast surface display;
this cell line is called D07-cells. To address the issue of a possible sticky end tethering
from the cells due to the pDisplay vector expressing a portion of protein on the surface of
the cell, pDisplay-cells were used. When the image analysis was conducted there were
few cells found on the surface of the PPyCl samples. Initially this was troublesome and a
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thorough evaluation of the binding assay needed to be performed to account for the lack
of cells. When evaluating the binding conditions of the cells to the surface of PPyCl, it
was obvious that the media was PBS/1%BSA, but this was not the binding media that the
Y2 antibody was initially selected in, that being SG-CAA media. Obviously an additional
binding assay was needed to analyze the binding of the Y2-cells in both medias. The
same conditions were applied and the interaction conditions were altered to include a set
of cells that were interacted and washed in SG-CAA media. Image analysis for this data
is presented in Figure 7.8 with supporting optical micrographs in Figure
7.9.
Figure 7.8: Image analysis of various cell lines binding to PPyCI in either PBS or
SG-CAA. Error bars = ±I SD.
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Image analysis of various cell lines binding to PPyCI
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Figure 7.9: Optical micrographs of various PC12 cell lines bound to PPyCl. 7.9A) PBS-
PC 12, 7.9B) PBS-D07, 7.9C) PBS-pDisplay, 7.9D) PBS-Y2, 7.9E) SGCAA-PC 12, 7.9F)
SGCAA-D07, 7.9G) SGCAA-pDisplay. 7.9H) SGCAA-Y2, Scale bar = 20 gm.
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From the image analysis data it was observed that there is a significant increase in
binding capacity of the Y2-cells when interacted in SG-CAA media, 1414 cells/mm2. As
for the other cell lines in SG-CAA media; there is very little binding with less than 130
cells/mm2. The binding of the varying cell lines in PBS/1%BSA as previously described
is minimal with the highest being that of D07-cells at 143 cells/mm2 . Thus from this data
the Y2-cells bind an order of magnitude better than the next best cell type in SG-CAA.
Additionally, there is an unanswered question that needs to be addressed which is, why
SG-CAA media facilitates binding and PBS/1%BSA does not? Could it be that there is a
component within the SG-CAA media that facilitates binding or is it that SG-CAA is
needed as a whole? If the later is the case, how much of a dilution of SG-CAA media is
needed for binding of Y2-cells?
These questions can be addressed by conducting a binding study of an Y2
displaying system with the single components and varying dilutions of SG-CAA. The
display system chosen for this technique was the yeast display system because of its ease
in up and down regulating the expression the antibody in the presence of galactose.
Single components for SG-CAA media consisted of galactose, bactocasoamino acids,
yeast nitrogen base, disodium hydrogen phosphate, and sodium dihydrogen phosphate
hydrate, and dilutions of complete SG-CAA were 0%, 25%, 50%, 75%, and 100%. The
binding assay was performed as the previous yeast selection techniques were with
expression of' the Y2 antibody of the surface of the yeast cell at a concentration of
lx107 cells/ml for 18 hrs in complete 100% SG-CAA at 300C with agitation. After
induced expression the concentration was determined by optical density at 600 nm and
approximately lx108 cells/ml were dispensed into appropriate tubes. The yeast were then
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centrifuged for 30 sec at 3,000 rpm to pellet and resuspended in either one of single
components or a dilution of SG-CAA. The 0.5 cm2 samples of PPyCl were sterilized as
before and pre-blocked for 5 min with the appropriate media. The yeast and PPyCl
samples were allowed to interact for 10 hrs at 250C with medium rocking. The samples
were rinsed twice 1 ml of appropriate buffer w/ 0.1% Tween and washed once with same
media for 4 hrs at 250C. The samples were then submerged in media and analyzed
optically. The imaged samples were then incubated in dextrose containing media to
facilitate grow off as previously described in Chapter 6. Figure 7.10 is the analysis of the
grow off of the Y2 yeast cells bound in varying media and Figure 7.11 are optical
micrographs supporting this data.
Y2 grow off after 36 hrs
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YNB BCAA Na2HP04 NaH2PO4SG-CAA 0'% SG-CAA 25% SG-CAA 50% SG-CAA 75% SG-CAA 100% Galactose
Various media
Figure 7.10: Y2 grow off in various media. Error bars = ±1 SD.
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Figure 7.11: Y2 yeast clones bound to PPyCl in various media. 7.11A) 0% SGCAA,
7.1 IB) 25% SGCAA, 7.1 1C) 50% SGCAA, 7.1 1D)75% SGCAA, 7.1 E) 100% SGCAA,
7.11 F) Bactocasoamino acids, 7.11 G) Galactose, 7.11 H) Na2HPO4, 7.111) NaH2PO4,
7.1 1J) Yeast Nitrogen Base. Scale bar = 20 gm.
It is shown from this data the 100% SG-CAA media initially had the most yeast
bound on its surface, but very close to that amount are 75% and 50% SG-CAA. There is a
large reduction of cells after these three dilutions with the next being that of the single
component galactose and 25% SG-CAA. The rest of the varying media were significantly
less than the above mentioned ones, with less than half the initial amount of cells on the
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surface of PPyCl, except for the galactose media. What is interesting about the galactose
media is that it bound Y2 displaying cells better than half of the dilutions and was the
best of the single component analysis. Possible reasons for this increase in binding may
be due to a region on the Y2 antibody that interacts with galactose thereby instigating a
slight change in secondary structure of Y2 providing the necessary structure for binding
to the surface of PPyCl. This change in structure is not initiated by any other media
components to the extent that it occurs in galactose. Fortunately, for the in vivo scaffold
work that could continue this work an introduction of galactose into media, to facilitate
uncommon cell types binding to PPyCl once transfected with a vector containing the Y2
insert, would not be deleterious; where as the introduction of the complete mixture of
SG-CAA could be. Thus galactose would be a cofactor in the binding of at least Y2-cells,
with the possibility of extrapolating these two entities into other mammalian cellular
systems.
As was performed for the tethering of PC12 cells to PPyCl through T59-GRGDS,
a 5 min rotational agitation was performed to determine if the Y2-cells could be removed
from the surface of PPyCl. Because the Y2-cells recognized PPyCl in SG-CAA serum-
free media this was the only media type used in the experiment.
Figure 7.12) 7.12A) Y2-cells interacted in SG-CAA with PPyCI, 7.12B) Y2-cells
interacted in SG-CAA with PPyCI after 5 min rotational agitation.
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The data from the optical micrographs of the Y2-cells interacted in SG-CAA with
PPyCl it is apparent that there is no significant lose of cells after 5 min physical
disruption of binding of the Y2 antibody expressed on the surface of the PC12 cell,
suggesting that the Y2-cell binding to PPyCl is at least as strong binder as the PC 12 cells
tethered to PPyCl through the T59-GRGDS peptide.
To initially analyze the idea above that the Y2-cells are at least as strong of a
binder as the T59-GRGDS peptide tethered cells, a competitive study was performed.
The experiment consisted of interacting lx105 Y2-cells with PPyCl in SG-CAA and
washing any unbound cells. The same concentration of T59 peptide previously used (15
gm) in the saturation of PPyCl for cellular studies was used to try and compete off the
Y2-cells from the surface of PPyCl. For the Y2-cells the SG-CAA media was removed
and replaced with 15 gm T59 peptide in PBS and interacted for 1 hr at 250 C with medium
agitation. Figure 7.13 represents this data.
Figure 7.13) 7.13A) Y2-cells bound to PPyC1 in SG-CAA, 7.13B) Y2-cells bound to
PPyC1 after interaction with 15 jgm T59-GRGDS for 1 hr.
Figure 7.13 optical micrographs reveal that 15 gm of T59 peptide interacted with
Y2-cells bound to PPyCl can not compete a significant amount of Y2-cells off the
surface, as can be seen by the lack of difference in cells from Figure 7.13A and Figure
7.13B. This finding suggests that the Y2-cells at least bound as well as the T59 peptide.
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7.3 Conclusions
The use of an antibody binding to an inanimate surface is a novel idea that can be
used in many applications such as constructing biological tethers to the surface and
attaching entities to the surface that would not normally do so. By selecting an antibody
through yeast surface display that will attach to the surface of PPyCl, a biological entity
has been found that will attach to an inanimate object. Furthermore, through standard
molecular biology techniques the Y2 portion of DNA has been removed from the yeast
system and incorporated it into a mammalian display vector. The plasmid, Y2-pDisplay,
was inserted into the a mammalian cell line, PC12, via a lipid mediated transfection
agent, Lipofectamine 2000TM, in the presence of 200 gg/ml Geneticin® to create a new
cell line, Y2-cells, which displays the Y2 antibody on the PC12 cell surface. Through
immunological labeling of the cells the presence of the Y2 antibody on the surface was
confirmed as well determining the amount of Y2 antibody on the surface of the PC12
cell. This was performed by flow cytometry using the QuantumTM MESF kit for
fluorescence reference with the arrival at approximately 3,100 Y2 antibodies per PC12
cell.
To focus more on the applications of this work a binding assay was needed to
evaluate the binding of the new created cell line, Y2-cells, to PPyCl. This was initially
conducted in PC12 cell accommodating media, PBS, but with little binding occurring the
media was altered to represent the media that the Y2 antibody was selected initially,
SG-CAA. The result was an order of magnitude increase in binding of the Y2-cells
compared to all other cell types, ordinary PC 12 cells, D07-cells (a semiconductor derived
antibody cell type), and pDisplay-cells (to evaluate the presence of the vector alone in
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PC12 cells). The use of the SG-CAA instead of PBS media for cell binding is an
interesting occurrence. Therefore, further analysis was performed to determine what if
any of the single components or dilutions of SG-CAA facilitated binding of the Y2
antibody to PPyCl. It became apparent after growing the Y2 yeast cells off the surface of
PPyCl that down to 25% SG-CAA was a sufficient concentration to bind cells to PPyCl,
but when the conducting the single component analysis, galactose was a main factor in
binding the cells to PPyCl. Thus, these experiments lead to the hypothesis that in the
presence of galactose one could bind Y2 displaying cells for the construction of an in
vivo scaffold for nerve regeneration. To determine if the Y2-cells could be removed from
the PPyCl by physical disruption a rotational agitation was performed with no significant
difference of the amount of cells on the surface after 5 min of agitation. As a capstone
experiment the T59 peptide was used to try and compete off the Y2-cells from PPyCl.
The result had it gone either way in favor of T59 or Y2-cells would have been quite
informative. From the data it is apparent that T59 can not compete off the Y2-cells from
the surface of PPyCl, suggesting that the binding of Y2 to PPyCl is at least as strong as
the bound between T59 and PPyCl, resulting in the no change in the amount of Y2-cells
on the surface of PPyCl.
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Chapter 8: Conclusions
8.1 Conclusions for the molecular recognition of PPyCI
As initially stated the objective of this work was to functionalize an existing
polymer such that it better mimics natural tissue for tissue growth and regeneration.
Numerous other processes have tried and accomplished this with intrusion into the bulk
properties of the polymer of interest, but the focus of this work is to modify the
polymer's cell binding capability while not altering the bulk properties. Through the use
of both phage display of peptide libraries and yeast surface display of scFv libraries the
surface of PPyCl has been modified to facilitate binding of neuronal phenotype cells. The
selection of both libraries was performed on PPyCl that does not deteriorate in the
presence of either binding media of TBS, SG-CAA, or F12.
The phage display of peptides provided a novel technique for the screening of a
biomedical interesting polymer. The selection of T59 from this screening was tested for
amplification effects and it was found to amplify as well as a clone selected from earlier
rounds and non-engineered wild type phage, suggesting that it was not selected as
apposed to other clones because of T59's ability to amplify better in E. coli. Binding
analysis confirmed that, through titer count, T59 bound an order of magnitude better than
two other clones from the same selection and wild type to PPyCl in 0.1% TBS-T for 1 hr
with release being initiated by a change in pH from 7.5 to 2.2. Fluorescent labeling of the
T59 bound to PPyCl showed significant increases when compared to random phage and
wild type.
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To further understand the binding mechanism of T59 to the surface of PPyCl
variants were created to compliment the T59 peptide. These peptide variants coupled
with the fluorescamine protein assay provided a quality technique for evaluating the
amount of peptide that was on the surface. The data from these studies revealed that the
aspartic acid in the 8th position on T59 could be responsible for binding to PPyCl. Since
the variant studies revealed that the last six amino acids (N-terminus to C-terminus)
contained the aspartic acid residue peptide variant were created to determine which of
these six are necessary to bind to PPyCl. Variants were created maintaining the charge of
the hexamer, the length, and alanine substitutions were made throughout the length of the
variant to evaluate the accompanying amino acids, besides aspartic acid, necessary for
T59 binding to PPyCl. From the back six variants binding assay it was determined that
aspartic acid can be replaced with glutamic acid, but not with asparagine to maintain the
same binding capability. Additionally, leucine and tyrosine are essential accompaniments
to aspartic acid with the best binder of this variant study being that of LDYAAA. Other
back six clones supported this conclusion with almost no binding capability when both
leucine and tyrosine are excluded from the variant. An interesting clone is that of
AADDAA, which showed to bind almost as good as the full back six.
The applicable use for the T59 peptide was to tether biological entities to the
surface of PPyCl, since PPyCl does not support single cellular attachment. To evaluate
the capabilities of T59 to do so it was modified on the C-terminus with a RGD, a cellular
binding epitope, with a glycine linker between the modification and the 12 th position of
T59. Cellular binding assays were performed and it was determined that the modified
T59 peptide provided attachment to both PPyCl and PC12 cells, thereby tethering the
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cells to the surface of PPyCl. Furthermore, the modified peptide provided single cellular
attachment and with the introduction of [5-NGF the cells differentiated while still bound
to PPyCl, showing the capabilities of the T59 peptide to provide biologically active
cellular attachment. The ability of serum containing media to attach PC 12 cells to PPyCl
was negated by a physical disruption showing that the T59-GRGDS tethered was able to
withstand the same physical disruption resulting in the presence of cells bound to PPyCl
through the T59-GRGDS peptide.
The yeast surface display library of scFv's was used as an alternative selection
technique which provided several advantages over the phage display system. First,
visually the yeast are 4-5 ptm in diameter and can easily be seen with an optical
microscope, compared to phage which are approximately 6 nm x 880 nm and require a
secondary label for visualization. The second advantage is the high specificity of scFv's
to antigens, compared to peptides used for the same purposes. The third advantage is the
ability to control the expression of the scFv's on the surface of the yeast using either
galactose or dextrose in the media to up-regulate or down-regulate, respectively. For
application purposes the yeast surface display system was used as a reverse engineering
approach. Instead of tethering PC 12 cells to PPyCl via a peptide linker, the scFv selected
from the yeast library was used to mediate binding of the cells to PPyCl. This was
accomplished by integration and expression of the PPyCl specific scFv into PC12 cells
for the cellular recognition of a biomedical applicable polymer.
The screening of the yeast surface display library resulted in obtaining nine
unique clones. Through binding assays two clones, Y2 and Y4, provided the best binding
capability to PPyC1. Of these two clones Y2 possessed the best ability to release from
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PPyCl when down regulated in dextrose media, leading to the conclusion that the scFv on
the surface of Y2 was conducting the binding to PPyCl, and not the cell wall proteins.
As described previously, the eventual use of the scFv was expression of it on the
surface of PC12 cells to mediate binding of the cells to PPyCl. Therefore the Y2 scFv
was first inserted into a mammalian expression vector, pDisplayTM. This portion was
confirmed by DNA sequencing and the new plasmid, Y2-pDisplay, was transfected into
PC12 cells using Lipofectamine 2000TM as a transfection agent. The presence of the
extra-cellular expression region of Y2-pDisplay was confirmed by fluorescence antibody
labeling, creating a cell line named Y2-cells. The amount of the scFv on the surface of
the PC12 cells was evaluated using the QuantumTM MESF high level kit (Bangs Labs)
and the data obtained estimated approximately 3,100 copies of the scFv on the surface.
The presence of the Y2 scFv on the surface of PC12 cells provides the opportunity to
evaluate the mediating capability of the scFv between the PPyCl surface and PC 12 cells.
The initial binding assay of Y2-cells and PPyCl in PBS was disheartening with very few
cells bound. A secondary assay was performed using both PBS and SG-CAA with Y2-
cells binding to PPyCl an order of magnitude better in SG-CAA than in PBS. This
incidental information led to the study of evaluating the necessary media components for
the Y2 scFv to bind to PPyCl. Various dilutions and all single components of SG-CAA
were evaluated for binding of Y2 to PPyCl, with the determination that galactose is
necessary for satisfactory binding of Y2 to PPyCl. Additional studies analyzing the Y2-
cells binding ability during physical agitation confirmed that the Y2 scFv binds the PC 12
cells well. A competition of T59 and Y2-cells binding to PPyCl resulted in the Y2-cells
still bound after interaction with the peptide, suggesting that the Y2 scFv binds at least as
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good as T59 to the surface of PPyCl, assuming that all the binding sites on the surface of
PPyC1 were consumed by the Y2-cells.
8.2 Suggested Applications
The idea to attach neuronal cells to a biomedical applicable polymer is only one
of many uses for this type of surface modification technique. For instance, previously
Schmidt et al [3] described the use of nerve guidance conduit for nerve regeneration
purposes. One area of improvement on this technology would be spatial control of the
placement of biomolecules, currently biomolecules are non-specifically bound to the
interior of the conduit and they state that a concentration gradient of varying
biomolecules would greatly affect the regeneration capabilities of this type of system. If
one were able to mask the surface of this conduit and supply multiple types of
biomolecules necessary when initiating nerve regeneration, then one would be able to
provide a concentration gradient of varying types of biomolecules and or cells, such as
nerve growth factor and Schwann cells. Furthermore, the ability of PPyCl to conduct
current in conjunction with the concentration gradient of varying biological entities could
greatly increase the effectiveness of the nerve guidance conduit compared to the nerve
autograft [60]. Additional work conducted by Cosnier et al [61, 62] suggests the use of
PPyCl for biosensors by attaching enzymes to the surface and monitoring the change in
current as the enzymes are utilized, ultimately diminishing the amount of enzymes on the
surface to an undetectable amount. A reusable surface would provide a large advantage
over the current process, by being able to use the sensor in the same capacity multiple
times. The incorporation of peptide linker would provide a major advantage over the
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current setup. First, by tethering such a small peptide, like T59, to the surface linked to an
enzyme there would be little decrease in current difference had it been just the enzyme
linked to PPyCl. Second, the ability to replenish the biosensor for multiple uses would
greatly increase the longevity of the sensor.
The same techniques could apply for scFv as provided for the peptide. But the
scFv has an additional use in the biomedical field. Using the scFv within the biomedical
field would provide a great asset by attaching native cells to polymer scaffolds for
seeding of those scaffolds. The use of scFv would proceed as follows: select scFv for
scaffold polymer, incorporate scFv into mammalian expression vector, culture native
cells from a damaged region for grafting, express the scFv on the surface the native cells,
seed the native cells expressing the scFv on to the polymer to facilitate adhesion of the
cells to the surface of the polymer, creating a cell supporting polymer scaffold, implant
the scaffold back into the damaged site for tissue repair. What is really beautiful about
this type of integration is the scFv libraries ability to select for nearly any polymer
scaffold, regardless of bulk properties. But as can be seen using PPyCl in nerve
regeneration the bulk properties of the polymer become an advantage rather than a
disadvantage in tissue regeneration.
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Appendix 1: Yeast Clone Homology
Y1: VH1-18 (NIH Ig: AB019441).
Y2: VH6-1 (NIH Ig: AB019441), and 02 (NIH Ig: X59312).
Y3: VH6-1 (NIH Ig: AB019441).
Y4: Not Applicable.
Y5: VH3-5 (NIH Ig: AB019440), V1-22 (NIH Ig: D86996).
Y6: VH- 18 (NIH Ig: AB019440).
Y7: VH4-34 (NIH Ig: ABO19439), B2 (NIH Ig: x02485).
Y8: VH1-69 (NIH Ig: AB019437), B2 (NIH Ig: x02485).
Y9: Not Applicable.
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